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General Introduction  
 
The advent of high-speed computers, availability of sophisticated algorithms, and state-
of-the-art computer graphics have made plausible the use of computationally intensive 
methods such as quantum mechanics, molecular mechanics, and molecular dynamics 
simulations to determine those physical and structural properties most commonly involved in 
molecular processes. The power of molecular modeling rests solidly on a variety of well-
established scientific disciplines including computer science, theoretical chemistry, 
biochemistry, and biophysics. Molecular modeling has become an indispensable 
complementary tool for most experimental scientific research. [1] 
Molecular modelling is  focused on  applying  the  fundamental  laws  of  physics  and 
chemistry  to  the  study  of  molecules.  The  ultimate  aim  is  to  create  models  and 
simulations,  which  can  help  by  predicting,  rationalizing, and  estimating  the  properties  of  
molecules  and  their  interactions.  Today,  computational  techniques performed  by  powerful  
computers  have  revolutionized  molecular  modelling to  the extent  that  most calculations  
could  not  be  performed  without the  use  of  a  computer. [2] 
It  allows  chemists  to  study  chemical  phenomena  by  running  calculations  on 
computers  rather than  by  examining  reactions  and  compounds  experimentally.  Some 
methods  can  be  used  to  model  not  only  stable  molecules,  but  also  short-lived,  unstable  
intermediates  and  even  transition  states.  In  this  way,  they  can  provide  information  
about  molecules  and  reactions, which  is  impossible  to  obtain  through observations. 
Molecular modelling and  computational  chemistry  is  therefore  both  an independent 
research area and a vital adjunct to experimental studies. [2] 
Quantum chemistry methods play an important role in obtaining molecular geometries 
and predicting various properties [3]. To obtain highly accurate geometries and physical 
properties for molecules that are built from electronegative elements, expensive ab initio/HF 
electron correlation methods are required [4-6]. Density functional theory methods offer an 
alternative use of inexpensive computational methods which could handle relatively large 
molecules. [7-16] 
Hetero-aromatic ring system is the pivotal part of any biologically active drug molecule. 
Hetero-aromatic rings are essential because they provide similarity with respect to the 
biologically active compounds within our body for e.g. all the nucleic acids, hormones, 
neurotransmitters etc. which constitutes one or the other hetero-aromatic ring [17]. 
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 Among many hetero-aromatic rings present, fused and pendent [1, 2, 4]-oxadiazoles are 
also ubiquitous feature of many pharmaceutical products. Compounds having five membered 
ring containing one oxygen and two nitrogen atoms are called oxadiazoles or furodiazoles in 
the older literature. [17]  
Druglikeness is a qualitative concept used in drug design, which is estimated from the 
molecular structure before the substance is even synthesized and tested. The calculation of 
drug-like property can give us better assumption of biological activity of certain molecule. 
The theoretical calculation and maintain of certain properties of a molecule can fulfill the 
parameters which are essential to show certain biological activity. Lipinski's rule of five is a 
rule of thumb to evaluate druglikeness or determine a chemical compound with a certain 
pharmacological or biological activity that would make it a likely orally active drug in 
humans. [18] 
Drug-likeness appears as a promising paradigm to encode the balance among the molecular 
properties of a compound that influences its pharmacodynamics and pharmacokinetics and 
ultimately optimizes their absorption, distribution, metabolism and excretion (ADME) in 
human body like a drug. [19, 20] 
Molecular physicochemical and the drug-likeness are the two most significant properties 
to be considered for a compound to become a successful drug candidate. It  is also important 
for drug development where a pharmacologically active lead structure is optimized step-wise 
for increased activity and selectivity, as well as drug-like properties as described by Lipinski’s 
rule [21].  
The QSAR is a knowledge-based method where a statistical prediction model is made 
about biological activity and the presence of molecular descriptors. The aim of carrying out a 
QSAR study is with the help of computational methods  the QSAR model can help evaluate 
biological activity; this is mostly done to reduce failure rate in the drug development process 
[22]. The historical aim of QSAR studies is to predict the specific biological activity of a series 
of test compounds.  
Nowadays the main objective of these studies is to predict biological activity of In-silico-
designed compounds on the basis of already synthesized compounds [23]. The molecular 
modeling and QSAR calculations are used in many fields specially, physics, chemistry, 





Multiple linear regression (MLR), which is one of the most common and simplest 
method for constructing QSAR models, was used in this study [32 –34]. The advantage of 
MLR is that it is simple to use and the derived models are easy to interpret. 
Our work is placed in the context of fundamental and original research on 1,2,4-
oxadiazole and their derivatives, the main objective of this work is the application of different 
methods of molecular modeling to predict the chemical reactivity and biological activities 
expected in new bioactive molecules studied. 
The structure of the memory, composed by five chapters, has been conceptually divided 
into two differentiated parts. On one hand, the theoretical background section, which is 
composed by chapter 1 and chapter 2. On the other hand, chapter 3, chapter 4 and chapter 5 
devoted to applications and results, deepens into specific practical applications. 
Next, the content of the chapters is briefly described 
 Chapter 1 : Overview of Synthesis,  Reactivity and Biological Activity of Oxadiazole 
We will present general information on the physicochemical properties, the various 
biological activities, some ways of synthesis and chemical reactivity of oxadiazole. 
 Chapter 2 : Molecular Modeling 
This chapter contains the main concepts and definitions related to computational 
methods   (quantum mechanics methods, Semi - empirical methods and molecular mechanics 
methods).  
 Chapter 3 : Geometric, Electronic Structure and Substituent effects of 1,2,4-oxadiazol-
5-Amine 
The third chapter contains a structural, electronic and energetic study of 1,2,4 -
Oxadiazol-5-Amine  and its derivatives. In this chapter we present the results of a 
comparative study on two methods used in the calculation of the density functional theory 
(DFT) and ab initio, as well, the substitution effect on energy and electronic parameters of the 
basic nucleus of 1,2,4-Oxadiazol-5-Amine. 
 Chapter 4 : Computational Study of  Structure -Property  Relationships (SPR) for 1,2,4-
oxadiazole-5-amine Derivatives 
This chapter highlights the importance of  a qualitative study of structure-property 




 Chapter 5 : QSAR Modeling of Some 3-(Aryl)-N-(Aryl)-1, 2, 4-Oxadiazol-5-Amine 
Derivatives  
In this chapter, we take a small apercu about QSAR study (QSAR History, Several 
Purposes and Applications of QSAR Models, molecular descriptors, Statistical 
Parameters........), then, we establish a quantitative relationship between physiochemical 
properties and biological activity of  a series of bioactive derivatives of 1,2,4 -Oxadiazol-5-
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1. Introduction  
Heterocyclic compounds are well known for their pharmacological  potential that is  
exploitable in the synthesis of new bioactive molecules. Moreover, nowadays  heterocyclic 
chemistry becomes more and more advanced in the development of new poly-heterocyclic 
compounds. These compounds are extremely  valuable because they possess not only the 
pharmacological potential owned by the heterocycles themselves, but also a new one due 
to the reciprocal influence between the contained Heterocycles. [1] 
Azolic derivatives such as thiazole, triazole, oxadiazole and thiadiazole are 
pharmacologically useful compounds and have been intensely investigated for various 
biological activities, due to their promising application in the medicinal chemistry. [1] 
Oxadiazole, a heterocyclic nucleus has attracted a wide attention for the chemist in 
search for the new therapeutic molecules. Oxadiazoles and their derivatives are considered 
as simple five membered heterocycles possessing one oxygen and two nitrogen atoms.  
Oxadiazole exists in different isomeric forms such as 1,2,4-,  1,2,5-, 1,3,4- and 1,2,3-










Electrophilic substitutions in oxadiazole ring are extremely difficult at the carbon 
atom because of the relatively low electron density on the carbon atom which can be 
attributed to electron withdrawal effect of the pyridine type nitrogen atom. However  the 
attack of electrophiles occurs at nitrogen, if oxadiazole ring is substituted with electron-
releasing groups. Oxadiazole ring is generally resistant  to nucleophilic attack. Halogen-
substituted oxadiazole, however, undergo nucleophilic substitution with replacement of 





































Figure I.1: Different isomeric forms of oxadiazole 
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halogen atom by nucleophiles. Oxadiazole undergo nucleophilic substitution similarly as 
occurring at an aliphatic sp2carbon atom. 
Nitrogen-oxygen containing heterocycles are of synthetic interest because they 
constitute an important class of natural and synthetic products,  many of which exhibit 
useful biological activities [2]. 
The interest in five-membered systems containing one oxygen and two nitrogen 
atoms (positions 1, 2, and 4) stems from the occurrence of saturated and partially saturated 
1,2,4-oxadiazoles in biologically active compounds and natural products [3,4].  
Oxadiazole rings have been introduced into drug discovery programs for several 
different purposes. In some cases, they have been used as an  essential part of the 
pharmacophore, favorably contributing to ligand binding [5]. In other cases, oxadiazole 
moieties have been shown to act as a flat, aromatic linker to place substituents in the 
appropriate orientation [6] as well as modulating molecular properties by positioning them 
in the periphery of the molecule [4].  It has also recently been shown that significant 
differences in thermodynamic properties can be achieved by influencing the water 
architecture within the aldose reductase active site by using two structurally related 
oxadiazole regioisomers [7]. Also, oxadiazoles have been used as replacements for 
carbonyl containing compounds such as esters, amides, carbamates, and hydroxamic esters 
[8]. 
In drug discovery and development, a number of compounds containing an 
oxadiazole moiety are in late stage clinical trials, including Zibotentan as an anti-cancer 
agent [9] and Ataluren for the treatment of cystic fibrosis [10]. So far,  one oxadiazole 
containing compound, Raltegravir [11], an anti-retroviral drug for the treatment of HIV 
infection, has been launched onto the marketplace.  
It is clear that oxadiazoles are having a large impact on multiple drug discovery 
programs across a variety of disease areas, including diabetes, obesity [12], inflammation 
[13] cancer [14] and infection [15]. Aside from being biologically active themselves, 1,2,4- 
oxadiazoles also present an important linking site, for instance, for terminal amino groups 
of biologically important molecules. There are many drugs containing 1,2,4-oxadiazoles 
also many molecules are under development stages. 
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2. Naturally Occurring Oxadiazoles: 
There are only few examples of natural products with oxadiazole core or a structure 
based on it . One among this is phidianidines A and B (Figure I.2), this is a 3-substituted 
indole alkaloid. Phidianidines A and B have been isolated by Carbone et al. from the aeolid 
opisthobranch Phidiana militaris [16]. They selectively inhibits dopamine transporter DAT 
and also acts as partial agonists of the μ opioid receptor [17]. Phidianidine A and B do not 
have cytotoxic action and therefore it can be used as CNS targets. Quisqualic acid is 
another example for naturally occurring oxadiazole (Figure I.2). This is a metabolite which 
is obtained from the seeds of Quisqualis indica and Q. fructus .Quisqualic acid is a strong 
agonist for α-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors and group I 















































Figure I.2: Example for naturally occurring oxadiazole 
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3. Physical Properties of Oxadiazoles 
Almost all of the oxadiazoles are solid at room temperature. Their color ranges from 
white to dark brown. They are soluble in polar solvents like chloroform and dimethyl 
formamide but insoluble in non-polar solvents like ethers, etc. [19]     
 
4. Chemistry of 1, 2, 4-oxadiazoles 
Compounds containing heterocyclic ring systems are of great importance both  
medicinally and industrially. As an example, five-membered ring heterocycles  containing 
two carbon atoms, two nitrogen atoms, and one oxygen atom, known as  oxadiazoles 
(Figure I.3), are of considerable interest in different areas of medicinal and  pesticide 
chemistry and also polymer and material science [20]. The level of interest is clearly 
shown, over years, the number of patent applications containing oxadiazole rings have 
increased considerably. Within drug discovery and development, a number of compounds 
containing an oxadiazole moiety are in late stage clinical trials, ataluren for the treatment 















Figure I.3: Isomeric forms of 1, 2, 4-oxadiazole 
 
5. Biological Significance of 1, 2, 4-oxadiazoles 
It is clear that oxadiazoles are having a large impact on multiple drug discovery 
programs across a variety of disease areas, including diabetes [21], obesity [22], 
inflammation [23], cancer [24] and infection, in turn leads to the chemists to think about 
introducing the oxadiazole rings into drug discovery programs for several different 
purposes,  Ataluren (Figure I.4) is one of the 1,2,4-oxadiazole containing compounds in 
clinical development. 
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ADX-47273 (Figure I.5) is a drug used in scientific research which acts as a 
positive allosteric modulator selective for the metabotropic glutamate receptor subtype 
mGluR5 [25]. It has nootropic and anti-psychotic effects in animal studies [26], and has 












Figure I.5: Structure of ADX-47273 
5.1. Anti-cancer Activity 
William. K. et al. [28] efforts to discover and develop the 3-aryl-5-aryl-1,2,4-
oxadiazole series of apoptosis inducers as potential anti-cancer agents, in which 5-(3-
bromo-2-furyl)-3-(4-chloro-2-methyl-phenyl)-1,2,4-oxadiazole (Figure I.6) was found to 











Figure I.4: Structure of Ataluren molecule 
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Figure I.6:  Structure of 5-(3-bromo-2-furyl)-3-(4-chloro-2-methyl-phenyl)-1,2,4-oxadiazole 
 
Ziedan. N. I. et al. [29] designed and synthesized a series of new indole-based 3,5-
disubstituted 1,2,4-oxadiazoles, In which ethyl N-[(1S)-5-amino-1-[5-[[4-(2-phenylethoxy) 
phenyl]methyl]-1,2,4-oxadiazole-3-carbonyl] pentyl]carbamate (Figure I.7) was possess in-











Figure I.7: Structure of EthylN-[(1S)-5-amino-1-[5-[[4-(2-phenylethoxy)phenyl]methyl]-
1,2,4-oxadiazole-3-carbonyl]pentyl]carbamate 
 
5.2. Anti-tubulin and Anti-mitotic Activity  
Bhaskar. C. D. et al. [30]  have designed and synthesized a small library of 3,5-
disubstituted-1,2,4-oxadiazole containing combretastatin A-4 (CA-4) analogs (Figure I.8 ) 
to increase the efficacy of the CA-4 as an anti-tubulin and anti-mitotic agent by 
substituting the cis-alkene bond with one of its bio-isosteres, the 1,2,4-oxadiazole ring. 
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R1: H, R2:Br  
Figure I.8: Structure of (CA-4) analogs 
5.3. Anti-bacterial Activity 
Piccionello. A. P. et al. [31]  developed two series of 1,2,4-oxadiazoles, among the  
series  of  molecules  N-[[5-(4-morpholinophenyl)-1,2,4-oxadiazol-3-yl]methyl] acetamide 











Figure I.9: Structure of N-[[5-(4-morpholinophenyl)-1,2,4-oxadiazol-3-yl]methyl] acetamide 
 
5.4. Anti-fungal Activity  
Sangshetti. J. N. et al. [32] discovered 5-[1-(1-methylsulfonyl-4-piperidyl) triazol-
4-yl]-3-phenyl-1,2,4-oxadiazole (Figure I.10 ) as equipotent with Miconazole against 
Cryptococcus neoformans . 
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Figure I.10 : Structure of 5-[1-(1-methylsulfonyl-4-piperidyl) triazol-4-yl]-3-phenyl-1,2,4-
oxadiazole 
5.5. Human Histone Deacetylase Inhibitors 
Ester. M. et al. [33]  developed 2-trifluoroacetylthiophene oxadiazole derivatives,  
in which 2,2,2-trifluoro-1-[5-[3-[[4-(1,3,4-oxadiazol-2-yl)phenoxy]methyl]-1,2,4-
oxadiazol-5-yl]-2 thienyl] ethanone (Figure I.11) exhibited potent and selective class II 













Figure I.11: Structure of 2,2,2-trifluoro-1-[5-[3-[[4-(1,3,4-oxadiazol-2-yl)phenoxy]methyl]-1,2,4-
oxadiazol-5-yl]-2 thienyl] ethanone 
 
5.6. Allosteric Modulators 
Packiarajan. M. et al. [34]  designed and synthesized a series of novel 1,2,4-
oxadiazole  derivatives,  in  which  [3-[3-(3-chlorophenyl)-1,2,4-oxadiazol-5-yl]azetidin-1-
yl]-(4,4-difluoro-cyclohexyl)  methanone  (a),  (4,4-difluorocyclohexyl)-[3-[3-(3-
fluorophenyl)-1,2,4-oxadiazol-5-yl]azetidin-1-yl]methanone (b), [3-[3-(3-chlorophenyl)-
1,2,4-oxadiazol-5-yl]azetidin-1-yl]-norbornan-2-yl-methanone (c) (Figure I.12) had shown 
considerable activity as a potent mGluR5 positive allosteric modulators. 
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(a) (b) (c) 
 
Figure I.12: structures of 1,2,4-oxadiazole  derivatives (a), (b) and (c) 
5.7. Anti- kinetoplastid Parasites 
Cottrell. D. M. et al. [15] synthesized 5-thiocyanatomethyl- and 5-alkyl-3-aryl-1,2,4 
oxadiazoles, evaluated for their activity against kinetoplastid parasites. 3-(4-








Figure I.13: Structure of 3-(4-Chlorophenyl)-5-(thiocyanatomethyl)-1,2,4-oxadiazole) 
 
5.8. Anti-convulsant Activity 
Hans-Joachim. L. et al. [35] developed a series of 3- and 5-aryl-1, 2, 4-oxadiazole 
derivatives and tested for anti-convulsant activity in a variety of models. 5-Phenyl-3-
(1,2,4-triazol-1-ylmethyl)-1,2,4-oxadiazole (Figure I.14) was protective in the PTZ model 
in rats with an oral ED50 of 25.5 mg/kg and in the MES model in rats with an oral ED50of 
14.6 mg/kg. 
CHAPTER I : Overview of Synthesis, Reactivity and Biological 









Figure I.14:  Structure of 5-Phenyl-3-(1,2,4-triazol-1-ylmethyl)-1,2,4-oxadiazole 
 
6. Synthesis of 1,2,4-oxadiazoles  
1,2,4-Oxadiazoles are generally prepared by  
(i) 1,3-dipolar cycloadditon of nitrile oxides with nitriles and;  
(ii) cyclocondensation of amidoximes with carbonyl-containing reactants; such as activated 
acids, acid chlorides and fluorides, acid anhydrides, esters and β-ketoesters [36]. 
6.1. Synthesis of 1,2,4-oxadiazoles via 1,3-dipolar 
Cycloaddition of Nitrile Oxides with Nitriles  
It was previously mentioned that 1,3-dipolar cycloaddition reactions are one of the 
most common methods for the synthesis of heterocyclic compounds. 1,2,4-Oxadiazoles 
were also prepared by the cycloaddition between nitrile oxides and nitriles, and 3,5-
disubstituted-1,2,4-oxadiazole derivatives were isolated from these reactions as illustrated 














Schema I.1:  Synthesis of 1,2,4-oxadiazoles via 1,3-dipolar cycloaddition of nitrile oxides 
with nitriles. 
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Augustine developed one-pot synthesis of 1,2,4-oxadiazoles from amidoximes and 
nitriles in the presence of PTSA/ZnCl2catalyst system as depicted in (Schema I.2) [38]. 
















Schema I.2:  Synthesis of 1,2,4-oxadiazoles from amidoxime and nitriles. 
 
6.2. Synthesis of 1,2,4-oxadiazoles by Cyclocondensation of Amido-
ximes with Carboxylic Acid Derivatives  
Cyclocondensation of amidoximes with carboxylic acids in the presence of a 
coupling reagent is most common method for the synthesis of 3,5-disubstituted-1,2,4-
oxadiazoles  (Schema I.3) [39]. The reaction consists of two steps; coupling and 
cyclization. Amidoximes are often either commercially available or easily prepared by the 
reaction of nitriles with hydroxylamine [40]. Activated carboxylic acid derivatives, such as 
acid chlorides and fluorides, esters and anhydrides, are also used for the formation of O-
acylated amidoxime intermediates. N,N-Carbonyl-diimidazole (CDI) [41], acyl-palladium 
complex [42],  N,N-dicyclohexyl-carbodiimide (DCC) [43], (N,N-dimethylamino) 
isopropyl chloride (DIC) [44], 1-[3 (dimethylamino)propyl]-3-ethylcarbodiimide (EDC) 
[45, 46] and 2-(1H-benzotriazole-1-yl)-1,1,3,3-tetramethyluronium tetrafluoroborate 
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Schema I.3:  Synthesis of 1,2,4-oxadiazoles from amidoximes and carboxylic acids. 
 
6.3. Other Methods for the Synthesis of 1,2,4-oxadiazoles 
Reactions of amidoximes with aldehydes gave 4,5-dihydro-1,2,4-oxadiazoles, instead 
of 1,2,4-oxadiazoles (Schema I.4) [42, 49]. Then, oxidation of dihydrooxadiazoles by using 
potassium permanganate, MnO2  or sodium hypochlorite furnished 1,2,4-oxadiazoles. 
Recently, Okimoto electrochemically oxidized dihydrooxadiazoles to 1,2,4-oxadiazoles in 



















Schema I.4:  Synthesis of 1,2,4-oxadiazoles via oxidation of 4,5-dihydro-1,2,4-oxadiazoles. 
 
7. N-substituted 1,2,4-oxadiazoles 
1,2,4-Oxadiazoles [50-52] and specifically their N-substituted (on the 3-, or 5-, or 
3,5-positions) derivatives is a  class of heterocyclic compounds evaluated in numerous 
therapeutic areas. They were found to be potent  anti-viral agents, [53]  muscarinic receptor 
antagonists, [54, 55] histamine H2 receptor antagonists, [56, 57] hypocholsterolemic 
agents [58]  and anti-inflammatories. [59, 60] 
The variety of their biological activities was  ascribed to the bio-isosteric 
replacement [61, 62] of an ester or amide functionality and the electronic effects of  the 
main heterocyclic ring. The latter was interpreted in terms of the hydrogen bonding 
capacity of the  pharmacophore.  
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A number of structure-activity relationship studies revealed that the attachment of an  
additional amine functional group to the heterocyclic core increased the efficacy of the 
compound, by  increasing the hydrogen bonding capacity of the pharmacophore. [54, 55] 
Furthermore, changes in hydrophilicity by introduction of side chains on the nitrogen atom 
also affected the biological activity. [53-55, 59, 60] 
 
7.1 Synthesis of N-substituted 1,2,4-oxadiazole 
For the synthesis of  N-substituted 1,2,4-oxadiazole derivatives Eloy and Lenaers 
[63, 64] have reported a two-step procedure: 
 Initially, formation of the 5-trichloromethyl- or 5-chloro-1,2,4-oxadiazole 
derivatives from a proper amidoxime and then, nucleophilic substitution of the 
trichloromethyl or chloro substituent by the desired amine. 
The same team discovered [63, 64] the formation of primary or secondary amine 
derivatives upon the reaction of  hydroximoyl chlorides with guanidine derivatives. These 
are widely used methodologies for the synthesis of the above mentioned heterocycles in the 
area of medicinal chemistry, though, in most of the cases, the first step is usually low to 
moderate yielded. 
A straightforward formation of 5-amino-substituted 1,2,4-oxadiazoles from 
amidoximes, relies on condensation with cyanoguanidine, [65]  N,N-dialkylcyanamides, 
[66]  diphenyl cyanocarbonimidate, [60]  phosphorous ylides, [67]  and  N,N΄-
dicyclohexylcarbodiimide (DCC), [68]  methodologies which suffer  generality or provide 
the products in low yields. (Schema I.5) 
Interestingly, to the best of our knowledge, the procedure  involving the DCC was 
demonstrated only with the reaction with benzamidoxime, under dry conditions  and the 
yield did not exceeded 54%, even when a bi-equimolar quantity of the carbodiimide was  
employed. [68] 
Our interest in the chemistry and biology of amidoximes [67, 69-72] has prompted us 
to investigate thoroughly this reaction, taking into account that a relatively large number of 
carbodiimides, as well as amidoximes  (or their precursors, nitriles) are nowadays 
commercially available. We envisaged that the construction in  a single step of the 1,2,4-
oxadiazole heterocyclic ring bearing an N-substituent at position 5 and a variety  of alkyl 
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1. Introduction  
 
Computational chemistry may be defined as the application of mathematical and 
theoretical principles to the solution of chemical problems. Molecular modelling, a subset 
of computational chemistry, concentrates on predicting the behaviour of individual 
molecules within a chemical system. The most accurate molecular models use ab initio or 
ʺfirst principlesʺ electronic structure methods, based upon the principles of quantum 
mechanics, and are generally very computer-intensive. However, due to advances in 
computer storage capacity and processor performance, molecular modelling has been a 
rapidly evolving and expanding field, to the point that it is now possible to solve relevant 
problems in an acceptable amount of time. [1] 
Molecular modeling can be considered as a range of computerized techniques based 
on theoretical chemistry methods and experimental data that can be used either to analyze 
molecules and molecular systems or to predict molecular, chemical, and biochemical 
properties[2-4]. It serves as a bridge between theory and experiment to: 
1. Extract results for a particular model. 
2. Compare experimental results of the system. 
3. Compare theoretical predictions for the model. 
4. Help understanding and interpreting experimental observations. 
5. Correlate between microscopic details at atomic and molecular level and 
macroscopic properties. 
6. Provide information not available from real experiments. 
All  molecular  calculation techniques  can  be  classified  under  three  general 
categories: 
 Quantum Mechanical Methods,  
 semi-empirical methods, and  









2. Quantum Mechanical Methods 
2.1. Schrödinger Equation  
The starting point of the following overview is the Schrödinger equation [5 - 8] in its  
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where the wave functions  Ψ and  Ψ are functions of all coordinates of the relevant 
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where I and  J  refer to the nuclei  i and  j refer to electrons. The first term in (3) is 
the operator of the kinetic energy of the nuclei. The second term is the operator of the 
kinetic energy of the electrons. The third term is  the potential energy of repulsions 
between the nuclei,     is the distance between the nuclei I and J with atomic numbers ZI 
and ZJ . The fourth term is the potential energy of the attractions between the electrons and 
the nuclei and     is the distance between electron  i and nucleus I. The last term is the 
potential energy of the repulsions between the electrons, rij is the distance between 
electrons  i and  j .  
 
 





2.2. The Born-Oppenheimer Approximations: simplifies the general 
molecular problem by separating nuclear and electronic motions. This approximation is 
reasonable since the mass of a typical nucleus is thousands of times greater than that of an 
electron. The nuclei move really slowly with  respect to the electrons. Thus, the electronic 
motion can be described as occurring in a field of fixed nuclei.  
We can use the Born-Oppenheimer approximation to construct an electronic 
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This Hamiltonian is used in the Schrödinger equation describing the motion of the 
electrons in the field of the fixed nuclei: 
 
Ĥ            =                                   ( )       
Solving this equation for the electronic wave function will produce the effective-
nuclear potential function Eeff that depends on the nuclear coordinates and describes the 
potential energy surface of the system. For bond electronic problem,     should satisfy two 
requirements: antisymmetricity and normalization.     should change sign when two 
electrons of the molecule interchange and the integral of     over all space should be equal 
to the number of electrons of the molecule. 
 
3. Hartree-Fock Self-Consistent Field Method  
Much of the difficulty of solving the Schrödinger equation stems from the need to 
simultaneously determine the energy of each electron in the presence all other electrons. In 
the Hartree-Fock (HF) method this is avoided by calculating the energy of each electron in 
the averaged staticfield of the others. Initially a guess is made of the electron energies.  
The energy of each electron is then calculated in the field of the initial electron 
configuration. This procedure is repeated in an iterative loop until convergence (Self-
Consistent referring to this iterative calculation).  





The Hartree-Fock method can therefore be thought of as a kind of mean-spherical 
approximation at the electron level. The difference between the Hartree-Fock energy and 
the energy for the full Schrödinger equation is called the correlation energy. Hartree-Fock 
calculations are sufficiently accurate to provide insight into many problems and they are 
widely used. As Hartree-Fock calculations have been applied to different problems it has 
however become increasingly clear that the correlation energy is of great significance 
indetermining the properties of a system. Efforts have therefore been made to improve on 
the Hartee-Fock energy. 
3.1. Post-HF Methods  
There a number of different methods that go beyond Hartree-Fock calculations, one 
of the widely used approaches is perturbation theory. In perturbation theory the Hartree-
Fock solution is treated as the first term in a Taylor series. The perturbation terms added 
involve the electron repulsion. One of the more common forms was developed by Møller 
and Plesset. The second order perturbation form is referred to as MP2. This form will be 
utilized in the present work.  
It should be noted that the electron-electron repulsion energy is not necessarily a 
small perturbation. In cases in which this term is large the application of perturbation 
theory can become more difficult.  
There are a number of other techniques to include electron correlation that can 
potentially provide very accurate results, such calculations can however become very time 
consuming and at present they tend to be used for small molecules with maybe 3-4 heavy 
(non-hydrogen)atoms. The molecules studied in the present work are somewhat larger and 
the decision has been made not to use such time-consuming methods. 
3.2. Moller-Plesset perturbation theory (MPn)   
The  Moller-Plesset  (MPn)  Perturbation Theory attempts to correct the HF theory, 
which as mentioned earlier provides an approximation for the repulsion term between 
electrons and determines the position of an electron solely with respect to the atom’s nu-
cleus and the average of other electrons. As this model is not quite accurate, the MP theory 
uses HF as a starting point and then corrects it for the attraction term between the nu-cleus 
and the electron as well as the position of an electron with respect to another electron.  





The number following MP, such as MP2 or MP3, indicates the number of perturbations, or 
approximation terms, used in the theory. Generally, the higher this number, the greater the 
accuracy of the method. 
3.3. Density-Functional Theory (DFT) 
DFT theory models electron correlation as a functional of the electron density, ρ. The 
functional employed by current DFT methods partitions the electronic energy via the 
Kohn-Sham equations [9, 10] into several terms : 
 
  =    +    +    +                              (6) 
 
where     is the kinetic energy term (arising from the motion of the electrons),    is 
the potential energy term that includes nuclear-electron and nuclear-nuclear interactions, 
   is the electron-electron repulsion term and      is the electron correlation term. All 
terms except nuclear-nuclear repulsions are functions of the electron density. The terms 
   +    +    represent the classical energy of the electron distribution, while      
represents both the quantum mechanical exchange energy, which accounts for electron 
spin, and the dynamic correlation energy due to the concerted motion of individual 
electrons. 
Pure DFT methods calculate      by pairing an exchange functional with a 
correlation functional and so are designated by the choice of combination. For example, 
BLYP combines Becke’s gradient-corrected exchange functional with the gradient-
corrected correlation functional of Lee, Yang and Parr [11]. 
DFT calculations fall into three general categories: local density approximations 
(LDA), generalised gradient approximations (GGA), and ʺhybridʺ combinations of DFT 
and Hartree-Fock terms. LDA exchange and correlation functionals only contain terms 
related to electron density- an approach that works for some bulk materials, but fails to 
accurately predict properties in isolated molecules. GGA (ʺnonlocalʺ) functionals contain 
terms that depend upon both the electron density and the density gradients. 
The gradient-corrected density functional method BLYP is capable of predicting 
intramolecular bond dissociation energies to within a few kJ/mol [12]. However, the 
generalised gradient approximation severely underestimates activation barriers for some 





reactions due to neglect of Coulomb ʺself-interactionʺ of the electrons [13]. This problem 
is remedied with hybrid methods that combine Hartree-Fock self-interaction corrections 
with density functional exchange and correlation. Examples of hybrid methods are B3LYP 
and B3PW91, where B3 denotes Becke’s three-parameter hybrid functional [14,15], while 
‘PW91’ and ‘LYP’ are gradient-corrected correlation functionals of Perdew and Wang [16] 
and, as above, Lee, Yang and Parr. 
 
4. Semi-Empirical Method 
Most molecular computations done by organic chemists, especially those examining 
minimum energy geometries, are done using this method because it provides the best 
compromise between speed and accuracy.  This method can be thought of as a hybrid of 
molecular mechanics-type models based on experimentally measured empirical data and 
pure theory quantum chemical, thus the name semi-empirical.  It uses the Schrödinger 
equation approximations, but in order to make the calculations less time-consuming, it only 
calculates the locations of valence electrons, not all electrons. For the inner shell electrons, 
empirical data from typical organic molecules is used to estimate their locations.  
The semiempirical methods are presented by : 
 
 MNDO method (Modified Neglect of Diatomic Overlap) [17] which takes in 
account the repellencies between the electrons  pairs and the electron-electron perellence 
directions; 
 
 ZDO method(zero differential overlap) is based on the Huckel method for the π 
electrons 
 
 CNDO method (Complete Neglect of Differential Overlap) which takes in 
account only the atomic orbital of spherical symmetry and assesses the repellence integrals 
as the orbital would be sphere. In this case are two methods CNDO/1 and CNDO/2 which 
are used for the spectrum parameters; 
 
 INDO method [18] (Intermediate Neglect of Differential Overlap) which includes 
the monoelectronic repellence integrals between atomic orbital of the same atom;  





 NDDO method (Neglect of Differential diatomic orvelap) which takes in account 
the orientation direction of the orbital; MINDO/3 [19] method is an particular case of the 
NNDO method which assesses the monoelectronic repellence integrals;  
 
 SAM1 (Semi-Ab-Initio Model 1) 
The final 1993 offering in Michael Dewar’s name was Semi-Ab-Initio Model 1 [20]. 
In SAM1, two-electron integrals are calculated using a standard STO-3G basis set 
(and hence the appearance ofab initioin the title). The resulting integrals were then scaled, 
and the Gaussian terms in the core–core repulsions were retained in order to fine-tune the 
calculations. 
 
 AM1 (Austin Model 1) 
Next came Austin model 1 (AM1), due toM. J. S. Dewaret al. [21]. AM1 was 
designed to eliminate the problems from MNDO caused by a tendency to overestimate 
repulsions between atoms separated by the sum of their van der Waals radii. The strategy 
adopted was tomodify the core–core terms bymultiplication of the Coulomb term with 
sums of Gaussian functions. In the original AM1 paper there are four terms in the Gaussian 
expansion. Each Gaussian is characterized by its position along the A–B vector and by its 
width. This significantly increased the number of parameters for each atom. 
The performances of the semiempirical method consist in the smaller cost of them 
and it their speed, but also in the fact they can determine some properties that can not be 
established experimentally. 
 
 PM3 (parameterized method 3) 
PM3 is the third parameterization of MNDO, and the PM3 model contains essentially 
all the same terms as AM1. The parameters for PM3 were derived by J. J. P. Stewart [22] 
in a more systematic way than for AM1, many of which were derived by ‘chemical 
intuition’. As a consequence, some of the parameters are quite different from those of 









5. Molecular Mechanics (MM) 
Molecular mechanics describes molecules in terms of “bonded atoms”, which have 
been distorted from some idealized geometry due to non-bonded van der Waals and 
Coulombic interactions. [23, 24] 
Molecular mechanics calculates the energy of a molecule and then adjusts the energy 
through changes in bond lengths and angles to obtain the minimum energy structure. 
Molecular mechanics models are useful in studying structures, conformational 
energies and other molecular properties, including vibrational frequencies, conformational 
entropies and dipole moments, etc. [25, 44]. 
 
5.1. Steric Energy 
A molecule can possess different kinds of energy such as bond and thermal energy. 
Molecular mechanics calculates the steric energy of a molecule (the energy due to the 
geometry or conformation of a molecule). Energy is minimized in nature, and the 
conformation of a molecule that is favored is the lowest energy conformation. Knowledge 
of the conformation of a molecule is important because the structure of a molecule often 
has a great effect on its reactivity. The effect of structure on reactivity is important for 
large molecules like proteins. Studies of the conformation of proteins are difficult and 
therefore interesting, because their size makes many different conformations possible.  
Molecular mechanics assumes the steric energy of a molecule to arise from a few, 
specific interactions within a molecule. These interactions include the stretching or 
compressing of bonds beyond their equilibrium lengths and angles, torsional effects of 
twisting about single bonds, the Van der Waals attractions or repulsions of atoms that 
come close together, and the electrostatic interactions between partial charges in a 
molecule due to polar bonds. To quantify the contribution of each, these interactions can be 
modeled by a potential function that gives the energy of the interaction as a function of 
distance, angle, or charge [23,29]. 
The total steric energy of a molecule can be written as a sum of the energies of the 
interaction: 
               =       +         +       +       +                         ( ) 





The bond stretching, bending and torsion interactions are called bonded interactions 
because the atoms involved must be directly bonded or bonded to a common atom. The 
Van der Waals and electrostatic (qq) interactions are between non-bonded atoms. 
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5.2. Examples of MM Force Fields :  In Common use are: 
 AMBER  
(Assisted Model Building with Energy Refinement) - primarily designed for the 
study of biomolecules such as proteins and nucleotides [45]. 
 
 CHARMM  
(Chemistry at HARvard Molecular Mechanics) - primarily designed for biological 
and pharmaceutical study, but has also been applied to micelles and self-assembling 
macromolecules [46]. 
 
 MMx (MM2, MM3, etc)  
 Optimised for structural and thermodynamic studies of small non-polar molecules 
[47]. MMx force fields include third- and fourth-order corrections to standard quadratic fits 
for the potential energy surfaces of bonds and bond angles, thus allowing for non-harmonic 
effects in molecular vibrations. The various MMx versions differ primarily in their 
parameterisations. The higher versions tend to be more modern and address deficiencies in 
their predecessors. However, for the newer versions such as MM4, parameters may not be 
available for all classes of molecules. 
 
 OPLS  
(Optimised Potentials for Liquid Simulations)-optimised for reproducing the physical 
properties of biomolecules in liquid solutions [47]. 
The authors are not aware of any published study discussing the use of AMBER, 
CHARMM, MMx or OPLS with energetic materials. Since these packages are optimised 
for biochemistry and pharmaceutical applications, it is unlikely that they will accurately 
reproduce the behaviour of energetic materials without further modification. However, it is 
likely they can be used for limited applications with only slight modification. 
 
 CFF 
The consistent force field (CFF) [48-51] was developed to yield consistent accuracy 
of results for conformations, vibrational spectra, strain energy, and vibrational enthalpy of 
proteins. There are several variations on this, such as the Ure-Bradley version (UBCFF), a 





valence version (CVFF), and Lynghy CFF. The quantum mechanically parameterized force 
field (QMFF) was parameterized From ab initio results. CFF93 is a rescaling of QMFF to 
reproduce experimental results. These force fields use five to six valence terms, one of 
which is an electrostatic term, and four to six cross terms. 
 
 DREIDING[52] 
DREIDING is an all-purpose organic or bio-organic molecule force field. It has been 
most widely used for large biomolecular systems. It uses five valence terms, one of which 




The Merck molecular force field (MMFF) is one of the more recently published force 
fields in the literature. It is a general-purpose method, particularly popular for organic 
molecules. MMFF94[53] was originally intended for molecular dynamics simulations, but 
has also seen much use for geometry optimization. It uses five valence terms, one of which 
is an electrostatic term, and one cross term. 
 
 MOMEC 
MOMEC[54] is a force field for describing transition metal coordination compounds. 
It was originally parameterized to use four valence terms, but not an electrostatic term. The 
metal-ligand interactions consist of a bond-stretch term only. The coordination sphere is 
maintained by nonbond interactions between ligands. MOMEC generally works reasonably 
well for octahedrally coordinated compounds. 
 
 GROMOS  
(Groningen Molecular Simulation) developed at the University of Groningen and  the 
ETH (Eidgenössische Technische Hochschule) of Zurich [55] is quite popular for 
predicting the dynamical motion of molecules and bulk liquids, also being used for 
modelling biomolecules. It uses five valence terms, one of which is electrostatic [56]. Its 
parameters are currently being updated [57]. 
 





5.3. Energy Minimization and Geometry Optimization 
The basic task in the computational portion of MM is to minimize the strain energy 
of the molecule by altering the atomic positions to optimal geometry. This means 
minimizing the total nonlinear strain energy represented by the force field equation with 
respect to the independent variables, which are the Cartesian coordinates of the atoms [58]. 
The following issues are related to the energy minimization of a molecular structure: 
 The most stable configuration of a molecule can be found by minimizing its free 
energy, G. 
 Typically, the energy E is minimized by assuming the entropy effect can be 
neglected. 
 At a minimum of the potential energy surface, the net force on each atom vanishes, 
there for the stable configuration. 
Because the energy zero is arbitrary, the calculated energy is relative. It is meaningful 
only to compare energies calculated for different configurations of chemically identical 
systems. 
 It is difficult to determine if a particular minimum is the global minimum, which is 
the lowest energy point where force is zero and second derivative matrix is positive 
definite. Local minimum results from the net zero forces and positive definite second 
derivative matrix, and saddle point results from the net zero forces and at least one 
negative eigenvalue of the second derivative matrix. 
 
6. Research Methods of Global Minimum 
The most widely used methods fall into two general categories: 
(1) steepest descent and related methods such as conjugate gradient, which use first 
derivatives,and 
(2) Newton Raphson procedures, which additionally use second derivatives. 
6.1. Steepest Descent Method: [59] depends on: 
1- either calculating or estimating the first derivative of the strain energy with respect to 
each coordinate of each atom and 
2- moving the atoms.  





The derivative is estimated for each coordinate of each atom by incrementally 
moving the atom and storing the resultant strain energy change. The atom is then returned 
to its original position, and the same calculation is repeated for the next atom. After all the 
atoms have been tested, their positions are all changed by a distance proportional to the 
derivative calculated in step 1. The entire cycle is then repeated. The calculation is 
terminated when the energy is reduced to an acceptable level. The main problem with the 
steepest descent method is that of determining the appropriate step size for atom movement 
during the derivative estimation steps and the atom movement steps. The sizes of these 
increments determine the efficiency of minimization and the quality of the result. An 
advantage of the first-derivative methods is the relative ease with which the force field can 
be changed. 
6.2. Conjugate Gradient Method:  
The conjugate Gradient Method is a first-order minimization technique. It uses both 
the current gradient and the previous search direction to drive the minimization. Because 
the conjugated gradient method uses the minimization history to calculate the search 
direction and contains a scaling factor for determining step size, the method converges 
faster and makes the step sizes optimal as compared to the steepest descent technique. 
However, the number of computing cycles required for a conjugated gradient calculation is 
approximately proportional to the number of atoms(N), and the time per cycle is 
proportional to N.  
The Fletcher-Reeves approach chooses a descent direction to lower energy by 
considering the current gradient, its conjugate, and the gradient for the previous step. The 
Polak-Ribiere algorithm improves on the Fletcher-Reeves approach by additional 
consideration of the previous conjugate and tends to converge more quickly. 
6.3. Newton-Raphson Method:  
The Newton-Raphson Method of energy minimization [23] utilize the curvature of 
the strain energy surface to locate minima. The computations are considerably more 
complex than the first-derivative methods, but they utilize the available information more 
fully and therefore converge more quickly. These methods involve setting up a system of 





simultaneous equations of size (3N-6)(3N-6) and solving for the atomic positions that are 
the solution of the system. Large matrices must be inverted as part of this approach. 
The general strategy is to use steepest descents for the first 10-100 steps (500-1000 
steps for proteins or nucleic acids) and then use conjugate gradients or Newton-Raphson to 
complete minimization for convergence(using RMS gradient or/and energy difference as 
an indicator). For most calculations, RMS gradient is set to 0.10 (you can use values 
greater than 0.10 for quick, approximate calculations). 
The calculated minimum represents the potential energy closest to the starting 
structure of a molecule. The energy minimization is often used to generate a structure at a 
stationary point for a subsequent single-point calculation or to remove excessive strain in a 
molecule, preparing it for a molecular dynamic simulation. 
 
7. Types of Calculations  
Computational chemistry (also called molecular modelling; the two terms mean 
about the same thing) is a set of techniques for investigating chemical problems on a 
computer. Questions commonly investigated computationally are: 
7.1.   Molecular Geometry:  
The shapes of molecules – bond lengths, angles and dihedrals. 
7.2. Geometry Optimization [60] is a standard computational chemistry 
calculation to find the lowest energy or most relaxed conformation for a molecule. The 
approach is the same for all levels of calculation, involving an iterative “jiggling” process 
like that described for molecular mechanics. 
At each step, the molecular geometry is modified slightly and the energy of the 
molecule is compared with the last cycle. The computer moves the molecule a little, 
calculates the energy, moves it a little more, and keeps going until it finds the lowest 
energy.  This is the energy minimum of the molecule and is obtained at the optimized 
geometry. Recall that the energies from molecular mechanics can only be used in a relative 
sense, while those from quantum electronic structure methods can be compared in an 
absolute sense, like heats of formation. 





7.3. Single Point Calculations [60] are often used in combination with a 
geometry optimization to investigate steric hindrance. In this case the method only 
performs one computational cycle to calculate the energy of a particular fixed geometry. In 
a thermodynamically controlled reaction, the energetic difference between two 
conformations is often due to steric hindrance.  If the product molecule optimizes in one 
conformation, you can use single point calculations to determine how much more energy is 
needed to form the non-preferred conformation.   
The structure drawing and manipulation part of the software will allow you to move 
only that part of the molecule that changes in the higher energy form, leaving the rest of 
the molecule optimized. 
The single point calculation performed on this modified molecule will give an energy 
that you can directly compare with the optimized energy to find the energy difference 
between the lower and higher energy conformers.  For example, the energetic difference 
between having a constituent in the axial or equitorial position on a cyclohexane ring can 
be determined. 
7.4. Transition State Calculations [60] can be thought of as the reverse of 
geometry optimizations. In this case, the method searches for a structure of maximum 
energy, a transient intermediate which cannot be isolated experimentally. For example, this 
type of calculation allows one to examine transition state energies and geometries of 
intermediates involved in carbocation rearrangements. 
The literature contains standard models that should use as the starting point for these 
calculations.  It takes a far amount of effort and experience to properly analyze transition 
state structures and energies. 
7.5. Electronic Density and Spin Calculations, Graphical Models 
and Property Maps [60] Allow visualization of electronic properties such as electron 
densities, electrostatic potentials, spin densities and the shapes and signs of molecular 
orbitals. The values for a particular property at each point in the 3-dimensional space 
around a molecule are displayed on the 2-dimensional computer screen as a surface of 
constant numerical value, often called an isosurface which can be rotated in any direction 





to study it.  Alternately, numerical variations of a given property (such as electron density) 
at a defined distance from the molecule can be displayed as property maps using color as a 
key yielding what is called a property map. Carrying out surface calculations and viewing 
their graphical representations are major activities in computational chemistry and can 
provide useful insight into the mechanisms of organic reactions.  
7.6. Chemical Reactivity: [61]  
For example, knowing where the electrons are concentrated (nucleophilic sites) and 
where they want to go (electrophilic sites) enables us to predict where various kinds of 
reagents will attack a molecule. 
7.7. IR, UV and NMR spectra: [61] these can be calculated, and if the 
molecule is unknown,  someone trying to make it knows what to look for. allow the 
calculation of infrared stretching and bending absorption frequencies and it is a lot of fun 
to view animations of these types of motions in molecules. The vibrational frequency of a 
two-atom system is proportional to the square root of the force constant (the second 
derivative of the energy with respect to the interatomic distance) divided by the reduced 
mass of the system (which depends on the masses of the two atoms).  
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Molecular modeling can be defined as the generation, manipulation, calculation, and 
prediction of realistic molecular structures and associated physicochemical as well as 
biochemical properties by the use of a computer. It is primarily a mean of communication 
between scientist and computer, the imperative interface between human-comprehensive 
symbolism, and the mathematical description of the molecule.[1] 
The types of predictions possible for molecules and reactions include [2]: 
•  Heats of formation 
•  Bond and reaction energies 
•  Molecular energies and structures (thermochemical stability) 
•  Energies and structures of transition states (activation energies) 
•  Reaction pathways, kinetics and mechanisms 
•  Charge distribution in molecules (reactive sites) 
•  Substituent effects 
•  Electron affinities and Ionization potentials 
•  Vibrational frequencies (IR and Raman spectra) 
•  Electronic transitions (UV/Visible spectra) 
•  Magnetic shielding effects (NMR spectra) 
Prediction of these properties has many applications in energetic materials research, 
including studies of synthesis pathways, reaction products and initiation mechanisms. 
Quantum chemistry methods play an important role in obtaining molecular 
geometries and predicting various properties[3]. To obtain highly accurate geometries and 
physical properties for molecules that are built from electronegative elements, expensive 
ab initio/HF electron correlation methods are required [4-6]. Density functional theory 
methods offer an alternative use of inexpensive computational methods which could 
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2. Mulliken population analysis (MPA) 
This population analysis is the oldest and one of the most widely used. MPA divides 
bond orbital populations equally between the two atoms of a bond. This approach is very 
simplified and does not take into consideration that one of bonded atoms can attract 
electrons markedly more than the second one. On the other hand, the simplicity of MPA is 
sometimes an advantage because the method can be easily used.[17] 
 
3. Electrostatic Potential Surface(MESP) 
The molecular electrostatic potential is the potential energy of a proton at a particular 
location near a molecule.  
 Negative electrostatic potential corresponds to an attraction of the proton by the 
concentrated electron density in the molecules (from lone pairs, pi-bonds, etc.) (colored in 
shades of red).  
 
 Positive electrostatic potential corresponds to repulsion of the proton by the atomic 
nuclei in regions where low electron density exists and the nuclear charge is incompletely 
shielded(colored in shades of blue). 
The more red / blue differences, the more polar the molecule. If the surface is largely 
white or lighter color shades, the molecule is mostly non-polar.  
The MESP may be employed to distinguish regions on the surface which are electron 
rich (subject to  electrophilic attack) from those which are electron poor (subject  to 
nucleophilic attack) and has been found to be a very convenient tool  in exploration of 
correlation between molecular structure and the physiochemical property relationship of 
molecules including bio molecules and drugs [18-23]. 
The electrostatic potential V(r) at any point in space around a molecule by charge 








                          ( ) 
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Where the summation runs over all the nuclei A in the molecule and polarization and 
reorganization effects are neglected. ZA is the charge of the nucleus A, located at RA and 
ρ(r') is the electron density function of the molecule. 
 
4. Dipole Moment  
An electric dipole consists of  a pair of charges of  equal magnitude and opposite 
signs (+q and  –q),  separate  by  a  distance  (r).  The  dipole  moment  of  an  electric  
dipole  is  a  vector directed  from  the  negative  to  the  positive  charge.  The magnitude  
of the  dipole moment is measured  in  Coulomb meters  (Cm)  or in  debye (D), where 1D = 
3.338*10-30 Cm. [24] 
If  the  positive and negative charges  in a molecule  do not overlap, the  molecule 
possesses a  permanent  dipole  moment  (µ)  (polar  molecule).  Molecular  dipole  moment  
is  usually calculated using the following formula: 
 
  =      ×                                    ( ) 
 
Where  r is the radius-vector of  an atom i from  the origin of  the coordinate system (Centre 
of charge or Centre of mass) 
   is the partial charge of atom i 
 The summation is over all atoms in the molecule. 
 
5. Heat of Formation (∆  ) 
The heat of Formation is known as the change in enthalpy accompanying the 
formation of one mole of a compound from its elements in their natural and stable states, 
under standard conditions of one atmosphere at a given temperature [25]. 
The quantum chemical and energy descriptors are useful parameters for describing 
QSAR of a chemical system. A more useful quantity the heat of formation of the 
compound from its elements in their standard state. 
This is equal to the energy required to ionize the valence electrons of the atoms 
involved. The heat of formation is defined as: 
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∆   =      +      −      +                                 ( ) 
 
Where       is the electronic energy,       is the nuclear-nuclear repulsion energy,      is 
the energy required to strip all the valence electrons of all the atoms in the system and 
       is the total heat of atomization of all the atoms in the system. 
 
6. Energies of the Frontier Molecular Orbitals HOMO and 
LUMO 
The  energies  of  the  frontier  orbitals  HOMO  ( highest  occupied  molecular  
orbital)  and LUMO  (lowest  unoccupied  molecular  orbital)  are  commonly  used  
descriptors  in  QSAR analysis.  They  reflect  the  reactivity  of  a  molecule.  A  higher  
HOMO  energy  suggests higher  affinity  of  a  molecule  to  react  as  a  nucleophile,  a  
lower  LUMO  energy  suggests stronger  electrophilic  nature  of  a  molecule. 
Additionally,  electrophilic  and  nucleophilic attack will  most  likely occur  at  atoms  
where  the coefficients  of the corresponding atomic orbitals  in  HOMO  and  LUMO,  
respectively,  are  large. [24] 
 
7. Substituent Effects on the Electronic Structure 
The measure of some important electronic properties such as ionization energy, 
electron affinity, etc., through the introduction of electron donating (ED) or electron 
withdrawing (EW)  substitutions follows a long established method in bio-chemical and 
molecular electronics engineering. [26-30] 
ED substituents (donor Substituents) can increase the energies of highest occupied 
molecular orbital (HOMO) and lowest unoccupied molecular orbital (LUMO) relative to 
that of bare molecule (M), allowing a significant modification of the molecular electronic 
properties.(FigureIII.1) 
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Figure III.1: Influence of energy level of the donor group (ED) 
 
EW substituents (Acceptor Substituents) can decrease the energies of lowest 
unoccupied molecular orbital (LUMO) and highest occupied molecular orbital (HOMO) 
relative to that of bare molecule (M), allowing a significant modification of the molecular 









Figure III.2: Influence of energy level of the acceptor group (EW) 
 
 
8. Material and Methods 
Initial calculations were optimized using HyperChem 8.03 software [31]. The 
geometries of 1,2,4-oxadiazol-5-amine and its derivatives; were first fully optimized by 
molecular mechanics, with MM+ force-field (rms = 0.001 Kcal/Å). Further, geometries 
were fully re-optimized by using RM1 method. 
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In the next step, a parallel study has been  made using Gaussian  09 program 
package[32], at various computational levels, HF/6-31++G(d, p) ,MP2/6-31++G(d, p) and 
B3LYP/6-31++G(d, p). 
 
9. Results and Discussion 
9.1. Geometric Structure of 1,2,4-oxadiazol-5-amine 
The optimized geometrical parameters of 1,2,4-oxadiazol-5-amine by ab initio/HF, 
ab initio/MP2 and DFT method listed in (Table III.1) are in accordance with numbering 




Figure III.3: 3D conformation of 1,2,4-oxadiazol-5-amine (GaussView 05) 










































CHAPITER III : Geometric, Electronic Structure and Substituent 





The efficiency of DFT/B3LYP method may be scrutinized by comparison with the 
results obtained by more elaborate calculation such as ab initio/HF and initio/MP2.  
We can note a good correlation between the ab initio and DFT for bond lengths. The 
dihedral angles of cycle of this molecule are 0° or 180°, therefore, the geometry of the 
1,2,4-oxadiazol-5-amine is planar.  
9.2. Mulliken Population Analysis of 1,2,4-Oxadiazol-5 Amine 
Mulliken population analysis is a good way to account for differences in electro-
negativities of atoms within the molecule and frequently uses for supporting the MEP 
contour map. MEP and Mulliken population method can be used for interpreting and 
predicting the reactive behavior of a wide variety of chemical systems in both electrophilic 
and nucleophilic reactions. 
Charge densities calculated by the ab initio/HF are similar than ab initio/MP2 and 
slightly different with regard to DFT method (Table III. 2). 
According to Mulliken population in the Table III. 2, we can see that the atoms O1, 
N2, N4 and N6 have negative charges which leads to electrophilic substitution, whereas 
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9.3. MESP of 1,2,4-oxadiazol-5 amine 
MESP is an important factor by  which  we  can  confirm  the  electrostatic  potential  
region distribution of size and shape of molecules as well as the total physiology  of  the  
molecules [33]. 
A portion of the molecule that has a negative electrostatic potential is susceptible to 
electrophilic attack. The red and blue regions in the  MESP  map refer to  the regions of 
negative and positive potentials and correspond to the electron rich  and  electron-deficient  






Figure III.4: 2D MESP and 3D MESP contour map for 1,2,4-oxadiazole-5-amine molecule. 








O1 -0.263 -0.275 -0.158 
N2 -0.296 -0.288 -0.288 
C3 0.168 0.172 0.119 
N4 -0.531 -0.510 -0.421 
C5 0.686 0.659 0.403 
N6 -0.676 -0.676 -0.525 
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The  MESP  map  of  1,2,4-oxadiazole-5-amine (Figure III.4) suggests  that  there  are 
three electron rich regions (yellow)  around oxygen atom and at nitrogen  N(2) and N(4)   
atoms  of the heterocyclic ring. The oxygen atom and nitrogen atoms reflect the most 
electronegative region and have excess negative charge. 
The  hydrogen  atom  attached  to  nitrogen bear the maximum brunt of positive 
charge (dark blue) as compared to the rest of the H atoms of the molecule. 
9.4. Substitution Effect on 1,2,4-oxadiazol-5 amine 
The calculated values of (methyl, ethyl) substituted 1,2,4-oxadiazol-5-amine and 
(cyanide, fluorine) substituted 1,2,4-oxadiazol-5-amine (Figure III.5) are given in (Table 
III.3), (Table III.4), (Table III.5). 
 
In Table III.3, heat of formation, dipole moment, HOMO (highest occupied molecular 
orbital), LUMO (lowest unoccupied molecular orbital) and their difference (∆E) are 
reported for 1,2,4-oxadiazol-5-amine and its derivatives. In (Table III.4), (Table III.5),net 
atomic charges are also reported. 
The final heat of formation of studied compounds is varying from-85.779 Kcal/mol 
to224.306Kcal/mol. The compound B6 has the lowest heat of formation and needs small 
change in enthalpy to form one mole of this compound, while the compound A6 has the 
highest heat of formation and needs large change in enthalpy to form one mole of this 
compound. 
The values of dipole moment are varying from 1.9405 Debye to 6.7711 Debye. It is 
stated that if the total dipole moment of certain structure increases, then its molecular 
 
 
Figure III.5: Scheme of 1,2,4-oxadiazol-5-amine systems 
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reactivity increases as well, and accordingly the given structure becomes more interacting 
with other systems strongly in solution [35]. 
 
As has been seen by calculating the effect of a substituent donor increase the energy 
of the HOMO and that of the LUMO, while we see by calculating the effect  of a 
substituent acceptor decrease the energy of the HOMO and that of the LUMO , Results in a 




















A 1,2,4-oxadiazol-5-amine 36.542 7.029 0.679 6.349 3.2906 
A1 3-methyl-1,2,4-oxadiazol-5-amine 62.878 6.841 0.603 6.238 2.8683 
A2 3-ethyl-1,2,4-oxadiazol-5-amine 124.352 6.927 0.613 6.314 2.6675 
A3 N-methyl-1,2,4-oxadiazol-5-amine 78.363 6.679 0.581 6.097 3.7056 
A4 N-ethyl-1,2,4-oxadiazol-5-amine 136.697 6.664 0.559 6.105 3.7542 
A5 N,3-dimethyl-1,2,4-oxadiazol-5-amine 104.744 6.518 0.517 6.001 3.2257 





















153.190 8.456 2.757 5.699 3.4844 
B6 N,3-difluoro-1,2,4-oxadiazol-5-amine -85.779 7.612 1.292 6.319 3.7568 
 
Heat of formation (Hf)by RM1, ΔE and µ by DFT 
 
CHAPITER III : Geometric, Electronic Structure and Substituent 




9.4.1. Effect of Donor Substituents 
 
The heat of formation is increased at each addition of methyl and ethyl groups. 
In the substituted alkyl group category the negative atomic charge on nitrogen atoms 
is increased considerably for methyl and ethyl derivatives, except atom N6 is decreased 
considerably also oxygen O atom. 
In the mono-substituted alkyl group category, the N-methyl-1,2,4-oxadiazol-5-amine 
(compound A3) has smaller ΔE energy gap (6.097) (Table III.3) depicts the chemical 
reactivity of the compound; higher is the ΔE energy gap, lesser is the transfer of electrons to 
the higher energy state, making the molecule hard and less reactive. 
His maximum positive charge on 5rd position carbon (0.265) which leads to 
nucleophilic substitution (Table III.4). On the other hand in smaller ΔE gap, there is easy 
transfer of electrons to the higher energy state making it softer and more reactive (HSAB 
principle: hard and soft acids and bases). 
Hard bases have highest-occupied molecular orbitals (HOMO) of low energy, and 
hard acids have lowest-unoccupied molecular orbitals (LUMO) of high energy [36]. 
According to HSAB principle: compound A6 has the highest energy of  HOMO therefore, 
this  compound is soft base. And compound B5 has the lowest energy of LUMO therefore,  
this compound is soft acid compared to other compounds. 
Table III.4: Mulliken charges of 1,2,4-oxadiazol-5-amine and derivatives (series 1) 
 
Compound A A1 A2 A3 A4 A5 A6 
O1 -0.158 -0.114 -0.102 -0.154 -0.127 -0.097 -0.046 
N2 -0.288 -0.390 -0.371 -0.313 -0.312 -0.441 -0.463 
C3 0.119 0.619 0.384 0.204 0.217 0.762 0.613 
N4 -0.421 -0.437 -0.411 -0.368 -0.349 -0.400 -0.365 
C5 0.403 0.313 0.288 0.265 0.193 0.100 -0.073 
N6 -0.525 -0.525 -0.482 -0.389 -0.361 -0.377 -0.347 
C-methyl 3 ----- -0.698 ----- ----- ----- -0.662 ----- 
C-methyl N6 ----- ----- ----- -0.308 ----- -0.304 ----- 
C-1’ethyl 3 ----- ----- -0.308 ----- ----- ----- -0.201 
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In the case of dimethyl and diethyl substituted of 1,2,4-oxadiazol-5-amine the C-3 
position (compound A5) shows maximum charge (0.762), smaller EHOMO-ELUMO energy 
gap (6.001) (TableIII.3), (Table III.4) which leads to  preferential site of nucleophilic attack. 
9.4.2. Effect of Acceptor Substituents 
 
The heat of formation is increased at each addition of (fluorine substituted) while, 
cyanide-substituted is changing according to position of substitution. 
In the substituted acceptor group category, the negative atomic charge on nitrogen 
and oxygen atoms is decreased considerably  for cyanide and fluorine derivatives, except 
atom N2 is increased considerably except for compound (A3 and A4) (Table III.5). 
In the present work, we study cyanide and fluorine substituted 1,2,4-oxadiazol-5-
amine along the same line of methyl and ethyl substituted 1,2,4-oxadiazol-5-amine for a 
comparative study. 
C-2’ethyl 3 ----- ----- -0.504 ----- ----- ----- -0.504 
C-1’ethyl N6 ----- ----- ----- ----- -0.176 ----- -0.162 
C-2’ethyl N6 ----- ----- ----- ----- -0.439 ----- -0.458 
 
Table III.5:  Mulliken charges of 1,2,4-oxadiazol-5-amine and derivatives (series 2) 
 
Compound A B1 B2 B3 B4 B5 B6 
O1 -0.158 -0.073 -0.165 -0.131 -0.138 -0.031 -0.144 
N2 -0.288 -0.345 -0.319 -0.273 -0.268 -0.363 -0.301 
C3 0.119 0.784 0.558 0.225 0.163 0.866 0.622 
N4 -0.421 -0.402 -0.488 -0.325 -0.386 -0.325 -0.461 
C5 0.403 0.554 0.556 0.226 0.449 0.283 0.592 
N6 -0.525 -0.549 -0.535 -0.495 -0.235 -0.508 -0.245 
C-cyano 3 ----- -0.116 ----- ----- ----- 0.052 ----- 
N-cyano 3 ----- -0.562 ----- ----- ----- -0.549 ----- 
C-cyano N6 ----- ----- ----- 0.600 ----- 0.570 ----- 
N-cyano N6 ----- ----- ----- -0.399 ----- -0.385 ----- 
Fluro 3 ----- ----- -0.318 ----- ----- ----- -0.313 
Fluro N6 ----- ----- ----- ----- -0.131 ----- -0.124 
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In mono-substituted cyanide and fluorine derivatives,5-amino-1,2,4-oxadiazole-
3carbonitrile (compound B1) shows maximum charge on 3th position carbon (0.78) which 
leads to nucleophilic substitution (Table III.5) This is further supported by the least ΔE 
energy gap (5.69) (Table III.3) which depicts the chemical reactivity of the compound; the 
higher is the ΔE energy gap, the lesser is the transfer of electrons to the higher energy state, 
making the molecular hard and less reactive. 
In di-substituted cyanide and fluorine derivatives, (3-cyano-1,2,4-oxadiazol-5-yl) 
cyanamide (compound B5)  shows maximum charge on 3th position carbon (0.87) which 
leads to nucleophilic substitution (Table III.5)  is more reactive than N,3-difluoro-1,2,4- 
oxadiazol-5-amine (compound B6), this is due to smaller ΔE energy gap (5.69) (Table III.3). 
The compound B1 is predicted to be the most reactive with least ΔE energy gap of all 
1,2,4-oxadiazol-5-amine systems and is predicted to be the most soluble in the in polar 
solvents because it has maximum dipole moment value µ (6.77 D) (Table III.3).  
We note also that the cyanide substituent (acceptor effect) lowers the energies of 
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Figure III.6: Schematic drawings of the HOMO and LUMO of compound B1 
 
The contour plots of the π-like frontier orbital's for the ground state of compound B1 
are shown in (Figure III.6), The  positive phase  is  red  and  the  negative  one  is  green. 
from the plots, one can find that the HOMO mainly concentrates on N2 and the oxadiazole 
ring with some delocalization along N2-C3 and N1-C5-N4, whereas, the LUMO 
distributes over the whole molecule with some delocalization along C3- C-cyano and N4-
C5 These further demonstrate that there exists the delocalization of the conjugated π-
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The present work studied the molecular proprieties of 1,2,4-  oxadiazol-5-amine. The 
RM1, DFT and ab initio method can be used quite satisfactorily in predicting the chemical 
reactivity of the molecules and the effect of substitution of either donor or acceptor 
electron. 
The donor substituents (methyl and ethyl) increases the energy of HOMO and slight 
augmentation of energy of LUMO, and for acceptor substituents (cyanide and fluorine) had 
caused decreasing in HOMO and LUMO energy levels. 
The 5-amino-1,2,4-oxadiazole-3-carbonitrile (B1) is predicted to be the most reactive 
with least ΔE energy gap of all 1,2,4-oxadiazol-5-amine systems and this  latter has the 
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1. Introduction  
 
The process of drug development is time-consuming and cost-intensive. Several years 
are required for lead identification, optimization, in vitro and in vivo testing before starting 
the first clinical trials [1, 2]. A new strategy introduced into drug discovery is structure–
property relationships (SPRs). This is complementary to SAR. The structures of compounds 
are correlated to their property performance. SPR allows medicinal chemists to understand 
how structural modifications improve properties for their scaffold. Thus, the established 
strategy of structure-based design is supplemented with the new strategy of “property-based 
design” by van de Waterbeemd et al., [3] the study and modification of structure to achieve 
property improvement. 
There are many reasons for a drug discovery project team to strive toward selecting 
leads with good drug-like properties and optimizing properties for their compound series 
during drug discovery. 
The process of drug discovery balances a relentless search for molecules that have 
structural features that produce: 
(1) Strong target binding using structure-based design and the structure–activity 
relationship (SAR) 
(2) High performance at in vivo barriers, using property-based design [3]  and the 
structure–property relationship (SPR) 
In the same way that design of structural features using SAR is known as structure-
based design, the design of structural features using SPR has become known as property-
based design [3]. How a medicinal chemist goes about balancing these often disparate 
processes is a matter of experience and strategy. [4] 
Here we carry out the Structure Activity/Property Relationship (SAR/SPR) studies 
which are attempting to enhance our understanding of fundamental processes and 
phenomena in medicinal chemistry and drug design [5-8] and to give us the correlation 
between molecular structures and properties [9-11] such as lipophilicity, polarizability, 
electronic and steric parameters. The molecular properties, used in the correlations, relate as 
directly as possible to the key physicochemical processes taking place in the target activity. 
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2. Structure-Property Relationships (SPR) Properties 
 
2.1. Molecular Volume And Surface Area  
Molecular volumes are often calculated by a numerical integration grid technique [12] 
that I can illustrate by considering the trivial problem of finding the volume of an atom 




Figure IV.1 shows a two-dimensional representation of the atom whose van der Waals 
radius is R, surrounded by a three-dimensional grid of equally spaced points. 
 
Figure IV.1:  Grid around atom 
 
The grid has its centre at the atom centre, and the edges of the grid correspond to the 
van der Waals radius. 
For each grid point in turn we calculate its distance from the centre and determine 
whether the grid point lies inside or outside the atom. If n is the total number of grid points 







                                   (1) 
 
For a polyatomic, we have to give special consideration to grid points that lie in the overlap 
region. Figure IV.2 shows two atoms, A and B, with radii RA and RB. The overlap region is 
labelled X. 
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Figure IV.2: Atoms A, B and overlap region X 
 
For atom A, we know that the volume is 
 
 
   .  We now surround atom B with a grid, 
as described above, and test each grid point in turn. If the grid point lies within sphere B, 
then we test to see if it lies in region X and so has already been counted as part of the 
volume of atom A. The algorithm proceeds until all atoms have been considered in turn. 
The molecular volume is found by adding all atomic contributions. There are similar 
methods for the estimation of molecular surface area. 
 
2.2. Molecular Refractivity (MR)  
The molar refractivity is a steric parameter that is dependent on the spatial array of the 
aromatic ring in the synthesized compounds. The spatial arrangement also is necessary to 
study the interaction of the ligand with the receptor. [13] 
This parameter is a measure of the volume occupied by an atom or  group of atoms. 
The molar refractivity is a constitutive-additive property that is calculated by Lorenz-







               (2) 
 
where n is the refraction index, Mw is the molecular weight, and ρ is the density. The 
(   − 1)/(   + 2) term provides a correction factor by defining how easily the substituent 
can be poralized, whereas the Mw/ρ term defines a volume. Molar refractivity is related to 
the lipophilicity, volume, and steric of the molecules. Moreover, it has been correlated with 
the London dispersive force that acts in the drug-receptor interaction.  
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2.3. Molecular Polarizability (Pol) 
Molecular Polarizability of a molecule characterizes the capability of its electronic 
system to be distorted by the external field, and it plays an important role in modeling many 
molecular properties and biological activities. [14] 
It is widely used to describe the inductive and dispersive interaction of a molecule or 
molecular system. In addition, polarizability values have been shown to be related to 
hydrophobicity and thus to other biological activities. It is one of the descriptors that are 
extensively used in QSAR study. 
Highly polarizable molecules can be expected to have strong attractions with other 
molecules. The molecular polarizabity (α) is also related to molecular refractivity (MR) by 





                                   ( ) 
 
2.4. Molecular Weight (MW) 
  Molecular weight descriptor has been used as a descriptor in systems such as transport 
studies where diffusion is the mode of operation. It is an important variable in QSAR 
studies pertaining to cross resistance of various drugs in multi-drug resistant cell lines. [15] 
Molecular weight is correlated with the size of the molecule. [4] 
  High molecular weight compounds are likely to show high toxicity as promiscuity of 
compounds is also likely to increase [16]. Additionally, the systemic clearance of a 
compound is inversely proportional to the molecular weight [17]. 
 
2.5. Hydration Energy (HE) 
Hydration energy is very important in the selectivity filter of ion channels where the 
drug is almost entirely strip from the hydration water. [18]   
Indeed, in the biological environments the polar molecules are surrounded by water 
molecules. They are established hydrogen bonds between a water molecule and these 
molecules. The donor sites of the proton interact with the oxygen atom of water and the 
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acceptor sites of the proton interact with the hydrogen atom. The first corresponds to the 
complex with the strongest hydrogen bond. These hydrated molecules are dehydrated at 
least partially before and at the time of their interaction. These interactions of weak energy, 
which we observe in particular between messengers and receivers, are generally reversible 
[19]. 
 
2.6. Partition Coefficient (Log P) 
One of the most important physicochemical properties much interest in QSAR studies 
is lipophilicity (or hydrophobicity). Because it directly relates to solubility in aqueous 
phase, to membrane permeation (an important factor contributing to the toxicity of 
chemicals), and to its contribution to ligand binding at the receptor site.  
The ability of a molecule to cross the biological membranes (permeability) is a very 
important bio-pharmaceutic parameter that governs the absorption, distribution, metabolism 
and excretion (pharmacokinetics) of a drug. 
Enroute to its bio-phase, the drug has to partition between the lipid bio-membranes 
and the aqueous biological fluids. Although constituents vary from one membrane to the 
other, major constituents of bio-membranes are phospholipids, cholesterol, sphingolipids, 
and glycolipids. (Figure IV.3) 
 
Figure IV.3: Polarity of different cellular milieus 
 
All of these lipids are amphipathic in nature. Therefore, to successfully cross the 
various bio-membranes and to reach its site of action, any drug molecule should have a 
balance between hydrophilic and lipophilic properties.  
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The partition coefficient P, defined as the ratio of molar concentration of a chemical 
dissolved at equilibrium in octanol phase Coct to its molar concentration in aqueous phase 







          (4) 
 
 
Figure IV.4: Schematic depictions of the partition of species 
between octanol and water 
 
Which [ ]  and [ ]  are the concentrations of the compound A in organic and 
aqueous phases, respectively.  
The best choice out of various non-polar and slightly polar solvents available is n-
octanol [23] because, it mimics the biological membranes in several aspects: 
 n-octanol has a saturated alkyl chain, 
 it has a hydroxyl group that can act as both hydrogen bond donor as well as 
acceptor, it dissolves water to the extent of 1.7 M,  
 and its solubility parameter (δoctanol=10) is close to that of biological membranes, 
for example skin (δskin=10). 
This combination of lipophilic chains, hydrophilic groups, ability to take up water 
molecules and similar solubility parameter gives n-octanol properties very close to those of 
natural membranes. 
LogP values between 0 and 3 constitutes an optimal window for passive drug 
absorption. A logP value below 0 means that the compound is hydrophilic, and hence it will 
have a good solubility but it may have poor permeability. Whereas, a logP value far higher 
than 3 means that the compound is highly lipophilic, hence, tends to favour absorption, and 
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renders the compounds more susceptible to metabolism and / or biliary clearance [24, 25]. 
The influence of  lipophilicity on the metabolic clearance of drugs is attributed mainly to the 
increased affinity of drugs for the enzymes [26] 
 
2.7. Number of Hydrogen Bond Donors and Bond Acceptors 
Hydrogen bonding is now seen as an important property related to membrane 
permeation. Various scales have been developed [27]. Some of these scales describe total 
hydrogen bonding capability of a compound, while others discriminate between donors and 
acceptors [28].  
Hydrogen bonds increase solubility in water and must be broken in order for the 
compound to permeate into and through the lipid bilayer membrane. Thus, an increasing 
number of hydrogen bonds reduces partitioning from the aqueous phase into the lipid 
bilayer membrane for permeation by passive diffusion. [4] Thus, the number of hydrogen 
bond donors and acceptors should be limited in order to minimize the stability of compound 
in aqueous media. 
In this work, hydrogen donor (HBD) is either N or O with an attached hydrogen H, 




Figure IV.5: Hydrogen bonding 
 
2.8. Druglikeness 
The term drug-like captures the concept that certain properties of compounds are most 
advantageous in their becoming successful drug products. The term became commonly used 
following the pivotal work of Lipinski and his colleagues at Pfizer [29]. Their work 
examined the structural properties that affect the physicochemical properties of solubility 
and permeability and their effect on drug absorption. The term drug-like property has 
expanded and has been linked to all properties that affect ADME/Tox. Although medicinal 
chemists and pharmaceutical scientists had used structural properties in various ways for 
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many years, rules became more prominent and defined in the field with the report by 
Lipinski et al [29]  of the “rule of 5,” or what has become known as the “Lipinski rules.” 
These rules are a set of property values that were derived from classifying key 
physicochemical properties of drug-like compounds. The rule of five is based on four 
properties of molecules; namely, molecular weight (MW), logP, number of hydrogen-bond 
donors (HBD) taken as equivalent to the number of –OH and –NH groups, and the number 
of hydrogen-bond acceptors (HBA) taken as equivalent to the number of oxygen and 
nitrogen atoms. A ‘flag’ is set if a molecule’s MW is greater than 500, its logP is greater 
than 5, the number of its HBDs exceeds 5 and the number of its HBAs exceeds 10. Because 
the values of the decision points for all of the property values are multiples of five, the 
above set of rules has been called the ‘Rule of Five’[29]. 
 
2.9.      Lipinski Rules 
         Although medicinal chemists and pharmaceutical scientists had used structural 
properties in various ways for many years, rules became more prominent and defined in the 
field with the report by Lipinski et al. [30] of the “rule of 5,” or what has become known as 
the “Lipinski rules.”  
These rules are a set of property values that were derived from classifying the key 
physicochemical properties of drug-like compounds. The rules were used at Pfizer for a few 
years prior to their publication and since then have become widely used. The impact of 
these rules in the field has been very high. This acceptance can be attributed to many 
factors: 
 The rules are easy, fast, and have no cost to use. 
 The “5” mnemonic makes the rules easy to remember. 
 The rules are intuitively evident to medicinal chemists. 
 The rules are a widely used standard benchmark. 
 The rules are based on solid research, documentation, and rationale. 
 The rules work effectively. 
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The rule states that the compounds are more likely to be orally bioavailable if they obey the 
following criteria :  
 hydrogen bond donors ≤5 (expressed as the sum of all OHs and NHs) 
 MW ≤ 500 
 logP ≤ 5  
 hydrogen bond acceptors ≤10 (expressed as the sum of all Ns and Os) 
Molecules that violate more than one of these rules may have problems with 
bioavailability. Therefore, this rule establishes some structural parameters relevant to the 
theoretical prediction of the oral bioavailability profile, and is widely used in designing 
new drugs. However, classes of compounds that are substrates for biological transporters 
such as antibiotics, antifungals, vitamins, and cardiac glycosides, are exceptions to the rule 
[30]. 
 
3. Results and Discussion 
 
3.1. Structural Comparison of the 1,2,4-oxadiazol-5-amine 
Derivatives 
Based on our conclusions on the effect of substitution on the 1,2,4-oxadiazol-5-
amine molecules. We chose a series of 1,2,4-oxadiazol-5-amine derivatives, these 
molecules have a biological activity , This  series of 1,2,4-oxadiazol-5-amine derivatives  
are given in (Table IV.1). Initially, we performed a structural comparison of this series. We 
used molecular mechanics, with MM+ force-field to calculate the stable conformations of 
this series. These molecules have a weak conformational flexibility, with regard to the 
other macrocycles of macrolide type [31-37]. 
 
3.2. Study of Structure-Property Relationships for 1,2,4-oxadiazol-
5-amine Derivatives 
We have studied six physical and chemical proprieties of a series of fifteen 1,2,4-
oxadiazol-5-amine derivatives (3-(Aryl)-N-(Aryl)-1,2,4-Oxadiazol-5-amines) [38] (Table 
IV.1) using HyperChem 8.03 software [39].  
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For example, (Figure IV.6) shows the favored conformation in 3D of the compound1 




QSAR proprieties are, The properties involved are: Surface area grid (SAG), molar 
volume (V), hydration energy (HE), partition coefficient octanol/water (logP), molar 
refractivity (MR), polarizability (Pol) and molecular weight (MW). 
 
Table IV.1: Structural comparison of the 1,2,4-oxadiazol-5-amine derivatives 

















Figure IV.6: 3D Conformation of compound 1 (HyperChem 8.03) 
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3.3. Structure Property Relationships 
Lipophilicity is a property that has a major effect on solubility, absorption, 
distribution, metabolism, and excretion properties as well as pharmacological activity. 
Lipophilicity has been studied and applied as an important drug property for decades. It can 
be quickly measured or calculated. Lipophilicity has been correlated to many other 
properties, such as bioavailability, storage in tissues, permeability, and volume of 
distribution, toxicity, plasma protein binding and enzyme receptor binding [4, 40] 
Polarizability values are generally proportional to the values of surfaces and of 
volumes, the decreasing order of polarizability for these studied 1,2,4-oxadiazol-5-amine is:  
Compound 12 = Compound 13 > Compound 1 > Compound 14 > Compound 5= 
Compound 11 > Compound 9 > Compound 2 > Compound 15 = Compound 8> Compound 
10 > Compound 4 > Compound 3 > Compound 7 > Compound 6 (Table IV.2).  
The order of polarizability is approximately the same one for volume and surface. 
This also is explained by the relation between polarizability and volume, for the relativity 
non polar molecules. They are directly linked, for the centers of gravity of negative and 
positive charges in the absence of external fields to coincide, and the dipole moment of the 
molecule is zero. 
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Surface and distribution volume of these molecules are definitely higher than those of 
more polar molecules like the lipopeptides or beta-lactams. For example, Deleu et al. used 
Tammo software on the surfactins C13, C14 and C15 having cores similar to the macrolides 
[41]. 
They found that their surfaces vary from 129 to 157 Å2 [42], contrarily for these 1,2,4-
oxadiazol-5-amine derivatives, surfaces vary from 387.21 to 529.21 Å2. These 1,2,4-
oxadiazol-5-amine Derivatives  has a great variation of distribution  volume, in particular 
compound 12 and compound 13 which have  respective volumes: 1006.01 and 1005.22Å3 
(Table IV.2). 
  
















1 491.533 946.716 34.823 -7.912 96.903 2.410 309.368 
2 464.729 898.125 32.988 -9.527 92.621 2.256 295.341 
3 409.042 819.945 30.516 -8.128 86.246 3.249 265.315 
4 442.884 844.235 31.153 -10.109 88.020 1.860 281.314 
5 478.464 922.536 33.625 -10.427 94.394 0.867 311.340 
6 387.206 767.588 28.681 -8.713 81.645 2.853 251.288 
7 401.884 792.283 29.318 -11.532 83.738 1.706 267.287 
8 433.072 870.408 31.790 -11.669 90.112 0.713 297.313 
9 432.354 906.639 33.488 -13.878 94.518 -0.458 325.324 
10 414.982 861.669 31.653 -14.897 89.328 -0.090 311.297 
11 489.687 928.250 33.625 -11.841 94.860 1.056 311.340 
12 527.225 1006.009 36.097 -12.288 101.235 0.062 341.366 
13 529.205 1005.222 36.097 -12.218 101.235 0.062 341.366 
14 495.082 947.696 34.262 -13.163 96.487 -0.280 327.340 
15 455.565 871.702 31.790 -12.787 90.112 0.713 297.313 
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The most important hydration energy in the absolute value, is that of the compound 10 
(14.89 kcal/mol) and the weakest is that of compound 1 (7.91kcal/mol) (Table IV.2). 
Indeed, in the biological environments the polar molecules are surrounded by water 
molecules. They are established hydrogen bonds between them. 
Compound 10 has a site donor of the proton (NH) and six acceptor sites of the proton 
(O in Aryl group R1 and 2O in Aryl group R2) and 2N in the principal cycle and N6 of 
amine, but, in the oxygen O atoms, the acceptor effect is greatly reduced, because of the 
mesomeric effect. (Figure IV.7) 
 
Figure IV.7: Donor and acceptor sites of compound 10 
 
On the other hand, the compound 1 has a site donor of the proton (NH) and four 
acceptor sites of the proton (O in Aryl group R1) and 2N in the principal cycle and N6 of 
amine, but, in the oxygen O atoms, the acceptor effect is greatly reduced, because of the  
mesomeric effect (Figure IV.8).  
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This property supports the first compound, not only by fixing the receiver, but also 
activates it. It is thus about an agonist. It has as a consequence a better distribution in 
fabrics. 
The decreasing order of log P for these studied 1,2,4-oxadiazol-5-amine is:  
Compound 3 > Compound 6 > Compound 1 > Compound 2 > Compound 4 > Compound 7 
> Compound 11 > Compound 5 > Compound 8 = Compound 15 > Compound 12=  
Compound 13 > Compound 10 > Compound 14 > Compound 9   (Table IV.2). 
Compound 9 presents the low coefficient of division (-0.458) and comes after 
compound 14 (-0.280). These molecules possess a good solubility. When the coefficient of 
division is rather low, it has as a consequence a better gastric tolerance. 
Compound 3, 6 and 1 which have, respectively, higher values 3.25, 2.85 and 2.41; 
these molecules are the most absorbent products and have important capacities to be 
dependent on plasmatic proteins. 
 
3.4. Drug likeness Calculations on the Basis of Lipinski Rule of 
Five 
Druglikeness may be defined as a complex balance of various molecular properties 
and structure features which determine whether particular molecule is similar to the known 
drugs. These properties, mainly hydrophobicity, electronic distribution, hydrogen bonding 
 
Figure IV.8: Donor and acceptor sites of compound 1 
CHAPTER IV : Computational Study of  Structure -Property         




characteristics, molecular size and flexibility and presence of various pharmacophoric 
features influence the behavior of molecule in a living organism, including bioavailability,  
transport  properties, affinity to proteins, reactivity, toxicity, metabolic stability and many 
others [43].  
The druglikeness  was calculated by considering log P  (partition coefficient), number 
of hydrogen donor (HBD), number of hydrogen acceptor (HBD), molecular weight (MW) 
and number of violation. The druglikeness of various parameters of the isolated compounds 





Table IV.3: Lipinski’s rule of five for drug likeliness of 1,2,4-oxadiazol-5-amine derivatives. 
 
Compound MW (Da) logP HBD HBA 
No. of violations of 
Lipinski rule 
1 309.368 2.410 1 5 0 
2 295.341 2.256 1 5 0 
3 265.315 3.249 1 4 0 
4 281.314 1.860 1 5 0 
5 311.340 0.867 1 6 0 
6 251.288 2.853 1 4 0 
7 267.287 1.706 1 5 0 
8 297.313 0.713 1 6 0 
9 325.324 -0.458 1 7 0 
10 311.297 -0.090 1 7 0 
11 311.340 1.056 1 6 0 
12 341.366 0.062 1 7 0 
13 341.366 0.062 1 7 0 
14 327.340 -0.280 1 7 0 
15 297.313 0.713 1 6 0 
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We can see through the Table IV.3 that all compound have zero violation of Lipinski 
rule and all compounds have scores of less than 5 for lipophilicity, ranging from -0.458 to 
3.249. and its molecular weight  less than 500 Da, the maximum value of MW is  341.366 
Da for compounds 12 and 13. 
We can see also  from Table IV.3 that each compound has one hydrogen bond donor 
(NH) and all these compound have  hydrogen bond acceptors under 10 (Ns and Os) 
(Appendix C). 
Thus, all compounds meet the Lipinski rules of the five, suggesting that these 
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The present study, offers the ability to guide design and selection to quickly identify 
compounds from the 1,2,4-oxadiazol-5-amine derivatives series that are likely to achieve 
outcome in the clinic and occupy a strong market position. Also it provides a discussion of 
several qualitative approximations of the structure activity/property relationship. 
The compounds 3, 6 and 1 which have higher values of coefficient of division. These 
lipophilic compounds penetrate in various membranes, including cellular membranes as 
well as tissues with high lipoid content, to arrive at the receptor site.  
Compound 10 has important hydration energy leading to a better distribution in 
fabrics. 
 
Molecular properties such as membrane permeability and oral bioavailability are 
usually associated with some basic molecular descriptors, such as log P (partition 
coefficient), molecular weight (MW), and the acceptors and donor for hydrogen bonding in 
a molecule. Using these molecular properties, Lipinski established a controversial rule for 
drug design. 
The application of Lipinski rules on the studied 1,2,4-oxadiazol-5-amine derivatives 
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Quantitative structure-activity relationship (QSAR) analysis is based on the general 
principle of medicinal chemistry that the biological activity of a ligand or compound is 
related to its molecular structure or properties, and structurally similar molecules may have 
similar biological activities [1]. Such molecular structural information is encoded in 
molecular descriptors and a QSAR model defines mathematical relationships between 
descriptors and biological activities of known ligands to predict unknown ligands’ 
activities. QSAR methods have been applied in several scientific studies including 
chemistry, biology, toxicology and drug discovery to predict and classify biological 
activities of virtual or newly-synthesized compounds [2-5].  
QSAR describes the mathematical relationships between the structural attributes and 
target properties of a set of chemicals [6, 7]. QSARs are applied to predict the biological 
activities or ADMET properties of database molecules with similar chemical structures. 
This method is only fruitful if the dataset contains compounds that are structurally related 
to the molecules used to construct the model. 
Therefore, in contrast to lead discovery techniques, such as similarity analysis and 
pharmacophore modeling, QSARs are frequently used in the optimization phases of  drug 
design [8]. Many different 1D, 2D, 3D and multidimensional QSAR approaches have been 
developed during the past several decades [7, 9]. The major differences in these methods 
include the chemical descriptors and mathematical approaches that are used to establish the 
correlation between the target properties and the descriptors. 
QSAR analyses are often used to derive relationships between the molecular 
properties of compounds and their biological activities by statistical methods [10]. 
Many statistical methods have been employed to generate QSAR models from 
descriptive variables. Simple and multiple linear regressions is one of the more successful 
techniques use by many researcher in construct of QSAR models [11-13]. 
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2. QSAR History 
QSAR dates back to the 19th century. In 1863, A.F.A. Cros at the University of 
Strasbourg observed that toxicity of alcohols to mammals increased as the water solubility 
of the alcohols decreased.[14] In the 1890’s, Hans Horst Meyer of the University of 
Marburg and Charles Ernest Overton of the University of Zurich, working independently, 
noted that the toxicity of organic compounds were dependent on the lipophilicity. [14,15] 
Little additional development of QSAR occurred until the work of Louis Hammett,[16] 
Who correlated electronic properties of organic acids and bases with their equilibrium 
constants and reactivity. Hammett observed that adding substituents to the aromatic ring of 
benzoic acid had an orderly and quantitative effect on the dissociation constant. Hammett 
also observed that substituents have a similar effect on the dissociation of other organic 
acids and bases. QSARs based on Hammett’s relationship utilize electronic properties as 
descriptors. Difficulties were encountered when investigators attempted to apply Hammett-
type relationships to biological systems, indicating that other structural descriptors were 
necessary. 
Robert Muir, a botanist at Pomona College, was studying the biological activity of 
com-pounds that resembled indole acetic acid and phenoxyacetic acid, [17] which function 
as plant growth regulators. In an attempt to correlate the structures of the compounds with 
their activities, he consulted Corwin Hansch. Using Hammett sigma parameters to account 
for the electronic effect of substituents did not lead to a meaningful QSAR. However, 
Hansch recognized the importance of lipophilicity, expressed as the octanol-water partition 
coefficient, on biological activity. [18] 
This parameter is recognized to provide a measure of membrane permeability, since 
a compound needs to have lipophilic properties to enter a membrane and hydrophilic 
properties to pass through. The octanol-water partition coefficient is also a driving force 
when drugs bind into targets. 
QSAR models are now developed using a variety of parameters such as descriptors 
of the structural properties of molecules, descriptors to account for the shape, size, 
lipophilicity, polarizability, and other properties [19]   
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3. Several Purposes and Applications of QSAR Models : [20] 
 
 QSAR  models  are  used  to  predict  the  activity  of  new  (hypothetical)  chemical 
compounds,  even  before  their  synthesis.  Thus, QSARs can  save  time  and 
experimental resources for synthesizing and  biological testing of large numbers of 
compounds. QSARs offer possibilities for reduction or replacement of animal use in 
research and toxicity testing. 
 (Q)SARs  can  lead  to  better  understanding  of  the  mechanisms  of  interaction 
between  compounds and  biological systems. They may reveal important structural 
features for the biological effect. 
 QSAR  models  provide  useful  information  about  a  dose  range  for  a  biological 
effect of a compound, thus helping the experimental design  (selection of doses and 
tests) in drug research and toxicity testing. 
 
4. Main Steps in QSAR Analysis  
 
To  develop  QSARs,  a  series  of  compounds,  called  a  training  set,  is  used.  The 
compounds in the training set ideally ; the same or similar  mechanism of biological action  
to  ensure  that  the  same  factors  influence  the  activity  of  all  compounds  under 
investigation.  For  all  compounds  in  the  series,  biological  activities  are  evaluated  and 
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5. Tools and Techniques of QSAR 
 
5.1. Molecular Descriptors [21] 
The crucial point in the QSPR approach is an appropriate description of the 
molecular structures. The chemical descriptors take account of the different aspects of the 
chemical information. The molecular descriptor expresses chemical information 
transformed  and encoded from a molecule and effectively solves chemical, 
pharmaceutical, and toxicological problems. The advantage of theoretical molecular 
descriptors is in developing compounds that have never been synthesized or explored 
experimentally. Molecular descriptors are well known for their ability to establish linear 






















Figure V.1: The main steps in QSAR analysis 






Evaluation of the quality of 
the model(s) 
Modification of the training set 
and further statistical analyses 
Refined model(s) 
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5.1.1. Constitutional Descriptors 
Constitutional descriptors can simply obtain the information from the chemical 
composition of the compounds. Typical constitutional descriptors include molecular 
weight, total numbers of atoms, bonds, and rings in the molecule. These are one-
dimensional (1D) descriptors that can easily be obtained with knowledge of the molecular 
formula. Unfortunately, the linear relationship between constitutional descriptors and 
physicochemical properties cannot sufficiently prove that a physical mechanism reflects 
molecular interactions.  
 
5.1.2. Topological Descriptors  
Topological descriptors are two-dimensional (2D) descriptors obtained from 
information on the molecular topology; they express the atomic connectivity in the 
molecule and can be calculated from 2D graph representation of molecules [22].  
 
5.1.3. Geometrical Descriptors  
Geometrical descriptors are derived from three-dimensional (3D) structures of 
molecules defined by the coordinates of atomic nuclei and the size of the molecules 
represented [21]. Weighted holistic invariant molecular (WHIM) descriptors contain 
another prospective class of molecular geometric parameters, WHIM descriptors are 
obtained from the molecular (x, y, z) coordinates of the molecules with 3D structure, in 
which the descriptors capture detailed information on molecular size, shape, symmetry and 
atomic distribution. The derivation of WHIM descriptors can be obtained from centered 
molecular coordinates using the PCA approach from the weighted covariance matrix of 
atomic coordinates [23, 24].  
5.1.4. Molecular Descriptors 
Geometry, topology and atom-weights assembly (GETAWAY), encode the 
geometrical information obtained from the molecular matrix together with the topological 
information obtained from the molecular graph, as well as information from atomic 
weights [25].  
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5.1.5. Electronic Descriptors  
Electronic descriptors reflect the electronic structure of the molecule, based on 3D 
structure and the charge distribution in the molecule. The descriptors can be obtained from 
the calculation with ab  initio or semi-empirical approaches. 
 
5.2. Biological Parameters [26] 
In QSAR analysis, it is imperative that the biological data be both accurate and 
precise to develop a meaningful model. It must be realized that any resulting QSAR model 
that is developed is only as valid statistically as the data that led to its development. The 
equilibrium constants and rate constants that are used extensively in physical organic 
chemistry and medicinal chemistry are related to free energy values ΔG. Thus for use in 
QSAR, standard biological equilibrium constants such as Ki or Km should be used in 
QSAR studies. 
Likewise only standard rate constants should be deemed appropriate for a QSAR 
analysis. Percentage activities (e.g., % inhibition of growth at certain concentrations) are 
not appropriate biological endpoints because of the nonlinear characteristic of dose-
response relationships. These types of endpoints may be transformed to equi-effective 
molar doses. 
Only equilibrium and rate constants pass muster in terms of the free-energy 
relationships or influence on QSAR studies. Biological data are usually expressed on a 
logarithmic scale because of the linear relationship between response and log dose in the 
mid-region of the log dose-response curve. Inverse logarithms for activity (log 1/C) are 
used so that higher values are obtained for more effective analogs. Various types of 
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Table V.1: Types of biological data utilized in QSAR analysis 
 
Source of Activity Biological Parameters 
1. Isolated receptors 
Rate constants Log k 
Michaelis-Menten Constants Log 1/Km 
Inhibition constants Log 1/Ki 
2. Cellular systems 
 
Inhibition constants Log 1/IC50 
Cross resistance Log CR 
in vitro biological data Log 1/C 
Mutagenicity states Log TA98 
3. In vivo systems 
Biocencentration factor Log BCF 
In vivo reaction rates Log I (Induction) 
Pharmacodynamic rates Log T ((total clearance) 
 
5.3. Statistical Methods Used in QSAR Analysis [27] 
Statistical methods are an essential component of QSAR work. They help to build 
models, estimate a model's predictive abilities, and find relationships and correlations 
among variables and activities. A suitable statistical method coupled with a variable 
selection method allows analysis of this data in order to establish a QSAR model with the 
subset of descriptors that are most statistically significant in determining the biological 
activity. The statistical method can be broadly divided in to two: linear and non-linear 
method.  
In statistics a correlation is established between dependent variables (biological 
activity) and independent variables (physiochemical properties or molecular descriptor). 
The liner method fits a line between the selected descriptor and activity as compared to 
non-linear method which fit a curved between the selected descriptor and activity. 
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Following are commonly used statistical methods  
1.  Principal component analysis (PCA)  
2.  Cluster analysis  
3.  Simple liner regression  
4.  Multiple liner regression  
5.  Stepwise multiple liner regression  
6.  Principle component regression (PCR)  
7.  Continuum Regression  
8.  Partial least squares (PLS)  
9.  Genetic function approximation (GFA)  
10.  Genetic partial least squares (GPLS)  
11.  Logistic regression  
12.  K-Nearest Neighbor classification (KNN)  
13.  Neural Network  
14.  Discriminant analysis  
15.  Decision Trees  
16.  SIMCA  
17.  Canonical Correlation 
 
6. Multiple Linear Regressions 
The Multiple Linear Regression (MLR) [28] is an extension of the classical regression 
method to more than one dimension. MLR calculates QSAR equations by performing 
standard 
Multivariable regression calculations using multiple variables in a single equation. 
MLR expresses a single dependent variable (y) as a linear combination of multiple 
independent variables (x): 
 
  =     +     . . . +                           (1) 
 
Where a, b are the coefficients of the regression, and k is a constant, the regression 
model can be built in a stepwise manner.  
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7. Statistical Parameters 
 
7.1. Coefficient of Determination (R2) 
The coefficient of determination is found by squaring the correlation coefficient and 
is used as a m ore precise way to interpret the correlation coefficient. It is useful because it 
gives the proportion of the variance in one variable that is “explained” by the other 
variable. It represents the percent of the data that is the closest to the line of best fit. [29] 
The correlation coefficient can be determined by the mathematical formula: 
 
   =
∑    ,    −   ,    
  
   






                                         ( ) 
 
The coefficient of determination is such that 0 < R2 < 1, and the stronger the correlation (R 
is closer to 1).  
 
7.2. Correlation Coefficient (R)  
Correlation coefficient is a simple statistical measure of relationship between one 
dependent and one or more than one independent variables and it is use as a measure of the 
statistical fit of a regression based model in QSAR [30]. 
The value of r is such that -1 <  R < +1.  The + and – signs are used for positive 
linear correlations and negative linear correlations, respectively. If the predicted and 
observed values have a strong linear correlation r is close to 1, however if there is no linear 
correlation or a weak linear correlation r is close to 0.  
The value of the correlation coefficient can be strongly influenced by one outlying point. 
 
7.3. Fischer Statistic (F) 
The F-statistic is used to test the statistical significance of the regression.[31] Hence, 
the larger the F value is above the critical value (Appendix D), the better the regression.  
As can be seen from the equation below the F-statistic increases as the number of data 
points increase and the coefficient of determination increases. 
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                                      (3)  
 
In the above equation R  is the coefficient of determination, n is the number of data points, 
and ν represents the degrees of freedom. The degrees of freedom can be determined by 
subtracting one from the number of variables in the regression equation.[32] 
The formula compares the amount of variability between datasets to the amount of 
variability within datasets. 
 
7.4. Standard Deviation (S) 
Standard deviation (S) is a statistical measure of the spread or uncertainty around the 








=   =  
   
     
                                  (4) 
 
Where,   ,    is each individual data point,   is the mean of the data set, n is the number of 
data points, and p is the number of independent variables.  
If many data points are clustered tightly around the mean, then the standard deviation 
is small. However, if data points are scattered widely around the mean, then the standard 
deviation is large. A useful property of standard deviation is that, unlike variance, it is 
expressed in the same units as the data. 
We can define some parameters used in the regression: 
 Total sum of squares:    TSS = ∑ (  ,    −    )
                          (5) 
 Regression sum of squares:   RSS = ∑ (  ,    −   ,   )
             (6)      
 Error sum of squares:    ESS= ∑ (  ,    −    )
                           (7) 
  Regression identity:  TSS = ESS + RSS                                   (8)  
7.5. Variance (R) 
The variance is the average of the squared standard deviation from the mean. Sums of 
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squares are directly related to variances. 
 





                               (9) 
 
7.6. Quality Factor (Q) 
Quality factor is calculated by equation: 
 
                 =
 
 
                                             (10) 
 
Where r is variance and S is standard deviation. Over fitting and chance correlation, due to 
excess number of descriptors, can be detected by Q value. Positive value for this QSAR 
model suggests its high predictive power and lack of over fitting.[33] 
 
8. Analysis of Variance (ANOVA) 
 
Analysis of variance is generally used with linear regression to assess model 
selection. When selecting the best model, we seek to strike a balance between goodness of 
fit and parsimony. 
Analysis of variance (ANOVA) is a method for decomposing variance in a measured 
out-come in to variance that can be explained, such as by a regression model or an 
experimental treatment assignment, and variance which cannot be explained, which is 
often attributable to random error. Using this decomposition into component sums of 
squares, certain test statistics can be calculated that can be used to describe the data or even 





Table V.2: Table of Analysis of variance (ANOVA). 
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  =  
   
 
   −   − 1
   
 
Error n - p - 1 ESS= ∑(  ,    −    )
      =
   
  −   − 1
  
Total n - 1 





The degrees of freedom for the regression is the number of parameters in the 
regression equation. The degrees of freedom for error is    −   − 1. Finally, the total 
number of degrees of freedom is defined as               +          . The column MS 
refers to the mean squared error, which is defined as   /   for each row in the table V.2. 
 
9. Validation of QSAR Models  
The predictive powers of the equations were validated by leave–one–out (LOO) 
cross–validation method [34–47, 48], cross-validation is a practical and reliable method for 
testing the significance of a model. Hence, to validate the final models generated 
individually for different activities ⁄ properties, leave one-out method is used to do cross-
validation. The leave-one-out method consists of developing a number of models with one 
compound omitted at the time after developing each model. The omitted sample data are 
predicted and the difference between observed and predicted values (activities) is 
calculated. The predictive ability of the model is quantified in terms of the corresponding 
leave-one-out cross-validated parameters. The cross-validated parameters often used being 
PRESS (predicted residual sum of squares), SSY (sum of the squares of the response 
value),    
   (overall predictive ability), SPRESS or SCV (uncertainty of prediction), and PSE 
or Spred (predictive square error). These parameters are defined as below: 
 
                             = ∑    ,     −   ,    
 
                      (  ) 
                                        = ∑    ,    −   
 
                     (12) 
CHAPTER V : QSAR Modeling of Some 3-(Aryl)-N-(Aryl)-1, 2, 4-












 =    −
     
   
          (13) 








                  (14) 








                    (15) 




                       (16) 
                      PE =  .      (  −   )/√                           (17) 
Here,   ,    and   ,    are the experimental (observed) and predictive (calculated) 
values of the activity respectively.   is the mean value of y ,   . n is the number of 
compounds used, p is the number of parameters (descriptors) used in the model. For a 
reliable model, the    
   (or q2) values should be >0.6. The model is considered to be 
excellent, if    
   (or q2) is >0.9. The performance of the model (its predictive ability or 
predictive power) can be given by PSE (or Spred). 
The SPRESS as well as PSE are good parameters to be used for discussing the 
uncertainty in prediction. The lower the value of these parameters, the better will be the 
predictive ability of the model. 
It is argued that PRESS is a good estimate of the real predictive error of the model. If 
PRESS is smaller than SSY, the model predicts better than chance and can be considered 
statistically significant. The ratio PRESS⁄SSY can be used to calculate approximate 
confidence intervals of prediction of new observations (compounds). 
 
10. Observations With Large Influence on The Regression Model, 
Outliers 
Outliers  are  observations  that are  not  well  described  by the  regression  model  
(have  large residuals).  The  presence  of  outliers  can  seriously  bias  the  regression  
results  by  greatly influencing the values of  the  regression coefficients.  However, 
defining an  observation as an  outlier  is  subjective,  taking  into  account  specific  
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experimental  considerations. [20] 
However,  generally  observations  with  high  residuals  (usually  higher  than  ±2  times 
standard error) are considered as outliers. 
Studentised  residuals  (residuals  divided  by  their  standard  errors)  can  also  be  
used  to identify  outliers.  According  to  a  method  developed  by  Tenekedjiev  and  
Radojnowa (2001)  each observation  is  excluded  once  from  the  data set and  its  
studentised  residual  is calculated from a regression model of the remaining observations. 
After  testing the whole sample,  all  the  observations  whose  studentised  residuals  do  not  
lie  within  the  calculated confidence  interval  corresponding  to  a  chosen  significance  
level  are  rejected.  This procedure  (representing  a  single loop) is  repeated  until  either  a  
predetermined  number of loops  over  all  the  observations  are  executed,  or  some  loop  
does  not  reject  any  outliers (which is often the second one) [49].  
Outliers  can  be  present  for  different  reasons:  errors  in  the  measured  variable  
values, extreme  values  for  one  or  more  of  the  variables,  different  causality  for  the  
value  of  the dependent  variable  for  the  given observation.  In   some  cases,  
transformations  of  the  data can  be  applied,  or  additional  independent  variables  can  be  
included  into  the  model  to correctly describe the outliers. Also, separate models 
excluding outliers can be developed.[20] 
 
11. Limitation in the Fundamental Principle of the QSAR 
 
Any QSAR model will produce some degree of error. This is partially due to the 
inherent limitation to predict a biological activity solely based on the chemical structure. 
One can argue from the principles of chemistry that the molecular structure of a chemical 
is key to understanding its physicochemical properties and ultimately its biological activity 
and the influence on organisms. Since both molecular structure and physico-chemical 
properties are associated with the chemical itself, the relationship between structure and 
physicochemical properties should be apparent and, therefore, more accessible using the 
QSARs. 
In contrast, the biological activity of a chemical is an induced response that is 
influenced by numerous factors dictated by the levels of biological complexity of the 
system under investigation. [50] 
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12. Results and Discussion 
 
12.1. Data Set 
In  the  present  study  a  data  set  of  3-(aryl)-N-(aryl)-1, 2, 4-oxadiazol-5-amines as 
anti-proliferative agents as potential treatments for prostate cancer (20 molecules) 
presented in Table V.3, has  been  taken  from    literature [51].  
 The reported IC50 values (µM) have been converted to the logarithmic scale [pIC50], 
for QSAR study. 
 
12.2. Descriptors Generation 
Firstly, the twenty investigated molecules were pre-optimized by means of the 
Molecular Mechanics, with Force Field (MM+) included in HyperChem version 8.03 
package. [52] After that, the resulted minimized structures were further refined using the 
semi-empirical RM1 Hamiltonian implemented also in HyperChem. We chose a gradient 
norm limit of 0.01kcal/Å for the geometry optimization.  
The QSAR properties module from HyperChem (8.03) was used to calculate: molar 
polarizability (Pol), the molar refractivity (MR), partition coefficient octanol/water (log P), 
molar volume (MV), Surface area grid (SAG) and molar weight (MW). RM1 optimized 
geometry was used to calculate heat of formation        
°  . (Table V.4) 
The Quantum Chemical descriptors: dipole moment (DM), Energy of frontier 
orbital’s EHOMO and ELUMO and atomic net charges (qO1, qN2, qC3, qN4, qC5 and qN6) 
were computed using Gaussian 09W software [53] by using DFT/B3LYP with 6-31G basis 
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IC50 Chemical descriptors  
  MW        
°  EHOMO ELUMO MD Pol MR MV 
1 6.066 309.368 859.433 -0.213 -0.044 3.985 34.823 96.903 946.716 
2 5.796 295.341 833.390 -0.214 -0.045 2.055 32.988 92.621 898.125 
3 6.000 265.315 745.592 -0.216 -0.047 2.701 30.516 86.246 819.945 
4 6.000 281.314 803.329 -0.214 -0.045 2.101 31.153 88.020 844.235 
5 5.569 311.340 890.633 -0.210 -0.043 5.213 33.625 94.394 922.536 
6 6.194 251.288 715.528 -0.216 -0.047 2.769 28.681 81.645 767.588 
7 7.076 267.287 777.173 -0.207 -0.046 1.514 29.318 83.738 792.283 
8 5.569 297.313 864.871 -0.204 -0.045 5.079 31.790 90.112 870.408 
9 6.032 325.324 973.291 -0.205 -0.044 1.225 33.488 94.518 906.639 
10 5.745  311.297 945.743 -0.206 -0.047 2.187 31.653 89.328 861.669 
11 5.678 311.340 894.236 -0.204 -0.044 .6530  33.625 94.860 928.250 
12  6.041 341.366 983.068 -0.202 -0.040 1.606 36.097 101.235 1006.009 
13 5.824 341.366 982.574 -0.203 -0.039 3.324 36.097 101.235 1005.222 
14 6.420 327.340 951.490 -0.203 -0.038 3.072 34.262 96.487 947.696 
15 7.538 297.313 863.149 -0.205 -0.044 .6730  31.790 90.112 871.702 
16 5.658 313.331 729.633 -0.218 -0.048 5.246 32.897 92.430 902.520 
17 5.585 283.305 648.857 -0.216 -0.055 1.094 30.425 86.374 830.992 
18 5.796 269.278 619.418 -0.216 -0.055 1.133 28.690 81.773 775.091 
19 6.260  285.278 681.074  -0.206 -0.054 0.929 29.227 83.866 799.950 
20  6.018 331.758  640.078 -0.213 -0.048 2.690 33.718 94.829 901.338  
Table V.4. Continued 
Comp.  
Number 
LogP  SAG qO1  qN2 qC3 qN4 qC5 qN6 
1 2.410 576.813 -0.446 -0.155 0.168 -0.426 0.731 -0.792 
2 2.256 551.188 -0.445 -0.154 0.168 -0.416 0.729 -0.442 
3 3.249  507.531 -0.445 -0.154 0.173 -0.421 .7290 -0.792 
4 1.860 523.172 -0.445 -0.154 0.168 -0.416 0.729 -0.792 
5 0.867 565.367 -0.446 -0.156 0.167 -0.428 0.732 -0.792 
6 2.853 475.826  -0.445 -0.154 0.173 -0.421 .7290 -0.792 
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7 1.706 493.789 -0.448 -0.155 0.173 -0.421 0.729 -0.792 
8 0.713 533.353 -0.444 -0.152 0.173 -0.422 0.730 -0.797 
9 -0.458 557.520 -0.446 -0.152 0.168 -0.417 0.730 -0.797 
10 -0.090 527.502 -0.449 -0.150 0.168 -0.416 0.732 -0.798 
11 1.056 575.730 -0.448 -0.155 0.168 -0.417 0.728 -0.793 
12 0.062 616.681 -0.449 -0.161 0.165 -0.418 0.729 -0.793 
13 0.062 611.168 -0.450 -0.154 0.165 -0.425 0.730 -0.793 
14 -0.280 575.640 -0.450 -0.153 0.162 -0.424 0.730 -0.793 
15 0.713 537.934 -0.448 -0.155 0.168 -0.417 0.728 -0.793 
16 1.412 551.571 -0.447 -0.150 0.168 -0.424 0.734 -0.796 
17 2.648 513.490  -0.442 -0.149 0.184 -0.386 0.718 -0.792 
18 2.252 483.241 -0.442 -0.150 0.185 -0.386 0.719 -0.792 
19 1.105  496.360 -0.445 -0.152 0.185 -0.386 0.718 -0.793 
20  0.491 550.417 -0.448 -0.149 0.168 -0.414 0.730 -0.794 
 
12.3. Regression Analysis 
  A relationship between independent and dependent variables (physicochemical 
descriptors and biological activities, respectively) were determined statistically using 
regression analysis.  In the present work, Multiple Linear Regression MLR analysis of 
molecular descriptors was carried out using the stepwise strategy in SPSS version 19 for 
Windows. [54] 
 
12.4. Quantitative Structure-Activity Relationships Studies  
  In the present study we tried to develop best QSAR model to explain the correlations 
between the physicochemical parameters and the biological activities IC50 values of 1,2,4-
oxadiazol-5-amine derivatives. Among several QSAR equations the  best  QSAR  models  
were  selected  on  the  basis  of  various  statistical  parameters  such  as :  
correlation coefficient R which measures the degree of line association between two 
variables.  
 We have strong relationship if  R ∈[0.8, 1] or R ∈[-1, -0.8];  
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 moderate relationship if  R ∈[0.5, 0.8] or R∈[-0.8, -0.5]; and 
 weak relationship if  R ∈[-0.5, 0.5] , 
  squared  correlation  coefficient  (R2  >  0.6) which is relative measure of quality of 
fit.  Standard error  of estimate (SEE < 0.3) representing absolute measure of quality of fit, 
Fischer’s  value (F), F is the Fisher ratio, reflects the ratio of the variance explained by the 
model and  the variance due to the error in the regression. High values of the F–test 
indicate that the model is statistically significant. [55] 
After multiple regression analysis on the software SPSS the best statistically 
significant correlations generated along with pertinent statistical parameters are given 
below (model 1): 
 
Log (1/IC50) = 51,72 - 1,185 logP  + 2,694 POL  - 0,046 MV - 0.024 SAG - 0,119 MW - 
289,923 qO1 - 232,918 qC5.                                                             (model 1) 
 n = 20 ;  R = 0,847 ; R2 = 0,717 ; SEE = 0,333 ;  S = 0,498 ;  F = 4,349 ;  Q = 2,543 
 
Table V.5. Observed vs. calculated activity (by model 1)of 1, 2, 4-oxadiazol-5-amine 
derivatives 
 
Number pIC50 Obs. pIC50 pred. Residue 
1 6.066 5.802 0.263 
2 5.796 5.864 -0.068 
3 6.000 6.142 -0.142 
4 6.000 6.173 -0.173 
5 5.569 5.427 0.142 
6 6.194 6.453 -0.259 
7 7.076 6.959 0.116 
8 5.569 5.524 0.045 
9 6.032 6.183 -0.152 
10 5.745 5.762 -0.017 
11 5.678 6.009 -0.332 
12 6.041 6.004 0.037 
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13 5.824 5.945 -0.122 
14 6.420 6.724 -0.304 
15 7.538 6.629 0.908 
16 5.658 5.661 -0.004 
17 5.585 5.485 0.100 
18 5.796 5.741 0.055 
19 6.260 6.413 -0.153 
20 6.018 5.956 0.0611 
 
  We can see from Table V.5 that compound 15 has residual value (0.908) is higher 
than twice the standard error of estimate (0,666), therefore , The previous model has one 
outlier’s (compound 15). 
This outlier has been removed from the data set (number of molecules became (n = 
19)), and the multiple regression analysis has been repeated by the software SPSS, thus, 
We got another model highly significant (model 2) 
 
Log (1/IC50) = -10,926   - 1,070 logP  + 2,608 POL - 0,045 MV - 0.02 SAG - 0,109 MW - 
284,398 qO1 + 54,884 qC3 -162,999 qC5.                                                (model 2) 
   n = 19 ;  R = 0,952 ; R2 = 0,906 ; SEE = 0,149 ; S = 0,362;    F = 12,066 ;  Q = 2,629 
 
Table V.6: Observed vs. calculated activity of 1, 2, 4-oxadiazol-5-amine derivatives 
 
Residue pIC50 pred. pIC50 Obs. Number 
0.090 5.975 6.066 1 
0.049 5.747 5.796 2 
-0.165 6.165 6.000 3 
0.092 5.908 6.000 4 
0.078 5.490 5.569 5 
-0.140 6.334 6.194 6 
0.229 6.846 7.076 7 
-0.013 5.581 5.569 8 
-0.075 6.106 6.032 9 
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0.018 5.727 5.745 10 
-0.233 5.911 5.678 11 
0.102 5.939 6.041 12 
-0.086 5.909 5.824 13 
0.025 6.395 6.420 14 
-0.008 5.665 5.658 15 
0.063 5.521 5.585 16 
0.069 5.726 5.796 17 
-0.097 6.356 6.260 18 
0.000 6.018 6.018 19 
 
We can see from the Table V.6 that all residual values less than twice of standard 
error of estimate (0,666) therefore, there aren’t any an outlier. 
 
 
Figure V.2: Scatter Plot between the Observed and Predicted Activities of Model 2 
 
Figure V.2 shows the plot of linear regression predicted versus experimental values 
of biological activity of 1, 2, 4-oxadiazol-5-amine derivatives outlined above, including 
also the 19 compounds of the evaluation set. The plot for model 2 shows to be more 
convenient with R2 = 0.906. The evaluation set has a good distribution along the range of 
values of the training set, and none of the 19 compounds was detected as an outlier. 
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12.4.1.   Interpretation of the Model 2 (Most Significant) 
Model 2 shows a good correlation coefficient (R) of 0.952 between descriptors        
(Log P, POL, MV, SAG, MW, qO1, qC3 and qC5) and the anti-proliferative activity.  
Squared correlation coefficient (R2) of 0.906 explains 90.6% variance in biological 
activity. The R2 value is above 0.8, which suggest that a good percentage of the total 
variance in biological activity is accounted by the model. Low value of standard error of 
estimate (< 0.3) indicates the accuracy of the statistical fit. All the values of the  t-statistic  
are  significant  which  confirms  the  significance  of  each  descriptor. 
The calculated F value for the generated QSAR model exceed the tabulated F value 
by large margin as desired for a meaningful regression. Furthermore, the calculated F value 
also determines a confidence limit superior to 95% for this model. The positive value of 
quality factor (Q) for QSAR model 2 suggests its high predictive power and lack of over 
fitting, low standard deviation of the model demonstrates accuracy of the model.  
The correlation matrix for pIC50 and selected descriptors to build the  2D-QSAR 
model is shown in Table V.7. The parameters used in the Model 2 are almost Independent  
which can be seen from the correlation matrix. 
In model 2, the negative coefficient of logP indicates that the substituents which 
increase solubility in water will lead to increased activity.  Which relates to the 
hydrophobicity of the molecule, suggested that a decrease in the lipophilicity might 
increase the activity, This corresponds to the absence of hydrophobic binding sites in the 1, 
2, 4-oxadiazole-5-amine derivatives. 
It can be observed that high coefficients of atomic charges on atoms O1, C3 and C5 
(qO1, qC3 and qC5 respectively), thus, high negative and high positive charges for O1 and 
C3 respectively and low positive charge for C5 lead to increasing anti-proliferative 
activity. 
The charges allowed a physical explanation and electronic molecular properties 
contributing to anti-proliferative potency as the electronic character related directly to the 
electron distribution of interacting molecule at the site active.   




 Table V.7: Correlation Matrix for Model 2 
 
 log(1/IC50) LogP Pol MV SAG MW qO1 qC3 qC5 
log(1/IC50)       1.000         
LogP       0.008 1.000        
Pol      -0.234 -0.584 1.000       
MV       -0.245 -0.602 0.993 1.000      
SAG       -0.140 -0.568 0.897 0.902 1.000     
MW       -0.232 -0.810 0.915 0.916 0.802 1.000    
qO1       -0.299 0.660 -0.660 -0.664 -0.575 -0.678 1.000   
qC3        -0.019 0.515 -0.779 -0.749 -0.650 -0.654 0.796 1.000  
qC5        -0.010 -0.327 0.573 0.525 0.355 0.436 -0.646 -0.897 1.000 
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12.4.2.    Model Validation 
The last step in QSAR model development is model validation. In order to test the 
validity of the predictive power of selected MLR model 2, as opposed to traditional 
regression methods, the method of cross-validation estimates the trustworthiness of a 
model by predicting data. This method uses cross-validated fewer parameters: PRESS 
(predicted residual sum squares), SSY (sum of the squares of response value), R2cv 
(overall predictive ability), adjusted R2 and Q2 . 
The high Q2 value observed for derived QSAR model is indicative of its reliability in 
prediction of inhibitory activity, PSE (predictive square of error ), the lowest value of PSE, 
the better is the predictive power which indicates that the model has excellent correlation 
ability and SPRESS (uncertainty of prediction) which is used in deciding uncertainty of 
prediction. 
PRESS is an important cross-validation parameter as it is a good approximation of 
the real predictive error of the models. Its value being less than SSY points out that the 
model predicts better than chance and can be considered statistically important. To have a 
dependable QSAR model, PRESS/SSY should be smaller than 0.4. [56] The indication of 
the performance of the model is obtained from R2cv (the overall predictive ability). 
Data presented in Table V.8 indicate that for the developed model the ratio is 0.093. 
Our findings of R2cv for this QSAR model have been to be 0.906 for the second model. 
The high value of R2cv and R2adj are essential criteria for the best qualification of the 
QSAR models 2. 
 
 
Table V.8: Cross-validation parameters. 
  





2  Model  
0.222 2,367 0.093 0.108  0.012 0.906  .8310  0.907  2  
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To investigate the presence of a systematic error in developing the QSAR models, 
the residuals of predicted values of the biological activity (log (1/IC50) was plotted against 
the experimental values Table V.6, as shown in Figure V.3. 
The propagation of the residuals on both sides of zero indicates that no systemic 
error exists, as suggested by Jalali-Heravi and Kyani. [57] It indicates that this model can 
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QSAR analysis was performed to find the quantitative effects of  molecular structure 
of the compounds on their anti-proliferative activity. Various physicochemical parameters, 
especially partition coefficient ( Log P), POL, MV, SAG, MW, qO1, qC3 and qC5 can be 
used successfully for modeling anti-proliferative activity of 1, 2, 4-oxadiazole-5-amine 
derivatives.  
The Model 2 (Most significant) is used to predict inhibitory activity of the 1, 2, 4-
oxadiazole-5-amine derivatives investigated and close agreement between experimental 
and predicted values was obtained. The low residual activity and high cross validated R  2  
values (R  2 CV) observed indicated the predictive ability of the developed QSAR model. It 
indicates that this model can be successfully applied to predict the anti-proliferative 
activity of these classes of molecules.
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General Conclusion   
 
In this work, we applied the methods of computational chemistry on 1,2,4-  
oxadiazol-5-amine molecule, This study include: 
 Geometric, electronic structure and substituent effects.  
 Computational study of  structure -property relationships (SPR) for 1,2,4-
oxadiazole-5-amine derivatives 
 QSAR modeling of some 3-(Aryl)-N-(Aryl)-1,2,4-Oxadiazol-5-Amine 
derivatives  
Firstly, the results demonstrate that the structural and electronic comparison of  
nucleus of 1,2,4 -oxadiazole-5-amine present similar results using different calculation 
methods: semi-empirical method (RM1) and Ab initio and DFT quantum methods. 
Next, we studied the effect of substitution on the electronic and energy parameters of 
basic nucleus of 1,2,4-oxadiazole-5-amine. Indeed, this study allows us to predict the 
chemical reactivity of 1,2,4-oxadiazole-5-amine system, for example, compound A6 has 
nucleophilic character (soft base).  And compound B5 has electrophilic character (soft 
acid) compared to other compounds. 
The donor substituents (methyl and ethyl)  increases the energy of HOMO and slight 
augmentation of energy of LUMO, and for acceptor substituents (cyanide and fluorine) had 
caused decreasing in HOMO and LUMO energy levels.  
The 5-amino-1,2,4-oxadiazole-3-carbonitrile (B1) is predicted to be the most reactive 
with lowest ΔE energy gap of all 1,2,4-oxadiazol-5-amine systems and this  latter has the 
highest dipole moment thus, compound B1 more interacting with other systems strongly in 
solution. 
Then, the results of research on the structure-property relationship (SPR) of the 
1,2,4-oxadiazol-5-amine derivatives series have shown that  structural units involved in the 
biological activity. 
The compounds 3, 6 and 1 which have higher values of  partition coefficient.  
These lipophilic compounds penetrate in various membranes, including cellular 
membranes as well as tissues with high lipoid content, to arrive at the receptor site.  





Molecular properties such as membrane permeability and oral bioavailability are 
usually associated with some basic molecular descriptors, such as log P (partition 
coefficient), molecular weight (MW), and the acceptors and donor for hydrogen bonding in 
a molecule. Using these molecular properties, Lipinski established a controversial rule for 
drug design. 
The application of  Lipinski rules on the studied 1,2,4-oxadiazol-5-amine 
derivatives shows that all these compounds, theoretically, will not have problems with oral 
bioavailability. 
Finally, Quantitative structure activity relationship (QSAR) studies were performed 
on a series of 3-(aryl)-N-(aryl)-1,2,4-oxadiazol-5-amines as anti-proliferative agents, 
multiple linear regression analysis was performed to derive quantitative structure activity 
relationship models which were further evaluated internally for the prediction of activity. 
The developed models were cross-validated by the ‘leave one out’ technique as well as by 
the calculation of statistical parameters.  
The best QSAR model i.e., model-2 (R2=0.906, Fischer’s test value F=12.066) has 
acceptable statistical quality and predictive potential as indicated by the value of cross 
validated squared correlation coefficient (q2=0.907).  
The present investigation indicates the importance of the quantum chemical 
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3D Structure  and SMILE notation of 
1,2,4-oxadiazole-5-amine derivatives 
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Table of F (Fisher-Snedecor) 
 144 
 
ν1= degrees of freedom for numerator 
ν1= degrees of freedom for denominator 
 
F95 (ν1 ,ν2)     α=0.05 
 
ν2/ν1 1 2 3 4 5 6 7 8 9 10 12 15 20 24 30 40 60 120 ∞ 
1 161.44 199.50 215.70 224.58 230.16 233.98 236.76 238.88 240.54 241.88 243.90 245.94 248.01 249.05 250.09 251.14 252.19 253.25 254.31 
2 18.512 19.000 19.164 19.246 19.296 19.329 19.353 19.371 19.384 19.395 19.412 19.429 19.445 19.454 19.462 19.470 19.479 19.487 19.495 
3 10.128 9.5521 9.2766 9.1172 9.0135 8.9406 8.8867 8.8452 8.8123 8.7855 8.7446 8.7029 8.6602 8.6385 8.6166 8.5944 8.5720 8.5494 8.5264 
4 7.7086 6.9443 6.5914 6.3882 6.2561 6.1631 6.0942 6.0410 5.9988 5.9644 5.9117 5.8578 5.8025 5.7744 5.7459 5.7170 5.6877 5.6581 5.6281 
5 6.6079 5.7861 5.4095 5.1922 5.0503 4.9503 4.8759 4.8183 4.7725 4.7351 4.6777 4.6188 4.5581 4.5272 4.4957 4.4638 4.4314 4.3985 4.3650 
6 5.9874 5.1433 4.7571 4.5337 4.3874 4.2839 4.2067 4.1468 4.0990 4.0600 3.9999 3.9381 3.8742 3.8415 3.8082 3.7743 3.7398 3.7047 3.6689 
7 5.5914 4.7374 4.3468 4.1203 3.9715 3.8660 3.7870 3.7257 3.6767 3.6365 3.5747 3.5107 3.4445 3.4105 3.3758 3.3404 3.3043 3.2674 3.2298 
8 5.3177 4.4590 4.0662 3.8379 3.6875 3.5806 3.5005 3.4381 3.3881 3.3472 3.2839 3.2184 3.1503 3.1152 3.0794 3.0428 3.0053 2.9669 2.9276 
9 5.1174 4.2565 3.8625 3.6331 3.4817 3.3738 3.2927 3.2296 3.1789 3.1373 3.0729 3.0061 2.9365 2.9005 2.8637 2.8259 2.7872 2.7475 2.7067 
10 4.9646 4.1028 3.7083 3.4780 3.3258 3.2172 3.1355 3.0717 3.0204 2.9782 2.9130 2.8450 2.7740 2.7372 2.6996 2.6609 2.6211 2.5801 2.5379 
11 4.8443 3.9823 3.5874 3.3567 3.2039 3.0946 3.0123 2.9480 2.8962 2.8536 2.7876 2.7186 2.6464 2.6090 2.5705 2.5309 2.4901 2.4480 2.4045 
12 4.7472 3.8853 3.4903 3.2592 3.1059 2.9961 2.9134 2.8486 2.7964 2.7534 2.6866 2.6169 2.5436 2.5055 2.4663 2.4259 2.3842 2.3410 2.2962 
13 4.6672 3.8056 3.4105 3.1791 3.0254 2.9153 2.8321 2.7669 2.7144 2.6710 2.6037 2.5331 2.4589 2.4202 2.3803 2.3392 2.2966 2.2524 2.2064 
14 4.6001 3.7389 3.3439 3.1122 2.9582 2.8477 2.7642 2.6987 2.6458 2.6022 2.5342 2.4630 2.3879 2.3487 2.3082 2.2664 2.2229 2.1778 2.1307 
15 4.5431 3.6823 3.2874 3.0556 2.9013 2.7905 2.7066 2.6408 2.5876 2.5437 2.4753 2.4034 2.3275 2.2878 2.2468 2.2043 2.1601 2.1141 2.0658 
16 4.4940 3.6337 3.2389 3.0069 2.8524 2.7413 2.6572 2.5911 2.5377 2.4935 2.4247 2.3522 2.2756 2.2354 2.1938 2.1507 2.1058 2.0589 2.0096 
17 4.4513 3.5915 3.1968 2.9647 2.8100 2.6987 2.6143 2.5480 2.4943 2.4499 2.3807 2.3077 2.2304 2.1898 2.1477 2.1040 2.0584 2.0107 1.9604 
18 4.4139 3.5546 3.1599 2.9277 2.7729 2.6613 2.5767 2.5102 2.4563 2.4117 2.3421 2.2686 2.1906 2.1497 2.1071 2.0629 2.0166 1.9681 1.9168 
19 4.3807 3.5219 3.1274 2.8951 2.7401 2.6283 2.5435 2.4768 2.4227 2.3779 2.3080 2.2341 2.1555 2.1141 2.0712 2.0264 1.9795 1.9302 1.8780 











21 4.3248 3.4668 3.0725 2.8401 2.6848 2.5727 2.4876 2.4205 2.3660 2.3210 2.2504 2.1757 2.0960 2.0540 2.0102 1.9645 1.9165 1.8657 1.8117 
22 4.3009 3.4434 3.0491 2.8167 2.6613 2.5491 2.4638 2.3965 2.3419 2.2967 2.2258 2.1508 2.0707 2.0283 1.9842 1.9380 1.8894 1.8380 1.7831 
23 4.2793 3.4221 3.0280 2.7955 2.6400 2.5277 2.4422 2.3748 2.3201 2.2747 2.2036 2.1282 2.0476 2.0050 1.9605 1.9139 1.8648 1.8128 1.7570 
24 4.2597 3.4028 3.0088 2.7763 2.6207 2.5082 2.4226 2.3551 2.3002 2.2547 2.1834 2.1077 2.0267 1.9838 1.9390 1.8920 1.8424 1.7896 1.7330 
25 4.2417 3.3852 2.9912 2.7587 2.6030 2.4904 2.4047 2.3371 2.2821 2.2365 2.1649 2.0889 2.0075 1.9643 1.9192 1.8718 1.8217 1.7684 1.7110 
26 4.2252 3.3690 2.9752 2.7426 2.5868 2.4741 2.3883 2.3205 2.2655 2.2197 2.1479 2.0716 1.9898 1.9464 1.9010 1.8533 1.8027 1.7488 1.6906 
27 4.2100 3.3541 2.9604 2.7278 2.5719 2.4591 2.3732 2.3053 2.2501 2.2043 2.1323 2.0558 1.9736 1.9299 1.8842 1.8361 1.7851 1.7306 1.6717 
28 4.1960 3.3404 2.9467 2.7141 2.5581 2.4453 2.3593 2.2913 2.2360 2.1900 2.1179 2.0411 1.9586 1.9147 1.8687 1.8203 1.7689 1.7138 1.6541 
29 4.1830 3.3277 2.9340 2.7014 2.5454 2.4324 2.3463 2.2783 2.2229 2.1768 2.1045 2.0275 1.9446 1.9005 1.8543 1.8055 1.7537 1.6981 1.6376 
30 4.1709 3.3158 2.9223 2.6896 2.5336 2.4205 2.3343 2.2662 2.2107 2.1646 2.0921 2.0148 1.9317 1.8874 1.8409 1.7918 1.7396 1.6835 1.6223 
40 4.0847 3.2317 2.8387 2.6060 2.4495 2.3359 2.2490 2.1802 2.1240 2.0772 2.0035 1.9245 1.8389 1.7929 1.7444 1.6928 1.6373 1.5766 1.5089 
60 4.0012 3.1504 2.7581 2.5252 2.3683 2.2541 2.1665 2.0970 2.0401 1.9926 1.9174 1.8364 1.7480 1.7001 1.6491 1.5943 1.5343 1.4673 1.3893 
120 3.9201 3.0718 2.6802 2.4472 2.2899 2.1750 2.0868 2.0164 1.9588 1.9105 1.8337 1.7505 1.6587 1.6084 1.5543 1.4952 1.4290 1.3519 1.2539 






 ةقلح لوح يلصأ و يساسأ ثحب لمعلا اذھ يف1,2,4-oxadiazol-5-amine  عقوت وھ كلذ نم فدھلا و ةسناجتم ریغلاةیلاعفلا 
وطاشنلا يجولویبلا .ھتاقتشم و سوردملا بكرملل 
 ةاونلل ةینورتكللاا  و ةیلكیھلا رییاعملا1,2,4-oxadiazol-5-amine :ةیلاتلا قرطلا مادختساب اھباسح مت ةیساسلأا اھتلاح يف HF/6-
31++G(d, p) , MP2/6-31++G(d, p), RM1  وB3LYP/6-31++G(d, p).  و ةینورتكللاا رییاعملا ىلع رثؤت لدبتسملا ةعیبط
ةاونلل ةیوقاطلا  ل ةیساسلأا1,2,4-oxadiazol-5-amine مست ةریخلأا ةساردلا هذھ ناف عقاولا يف , عقوتب انل حةیئایمیكلا ةیلاعفلا  تاقتشمل
1,2,4-oxadiazol-5-amine .  
 ةیعون ةساردب مایقلا اضیأ مت دقوةینب – صئاصخSPR)(  تاقتشم نم ةلسلسل 1,2,4-oxadiazol-5-amineایجولویب ةطشنلا. 
ةینب ةیمكلا ةقلاعلا ةساردب انمق اریخأو – ) ةیجولویبلا ةیلاعف (QSAR  تاقتشم نم بكرم نیرشعل1,2,4-oxadiazol-5-amine 
 ةیئاصحلإا ةقیرطلا انمدختسا دقو (رثاكتلل ةداضم لماوع) ةیجولویب ةیلاعف مھلMLR  يضایر جذومن میمصتل كلذو QSAR  ؤبنتلا ضرغل
.جذومنلا اذھ قیرط نع ةیجولویبلا ةیلاعفلل ةیرظنلا میقلاب  
 جذومنلا اذھ ةیلاعف و ةحص نم دكأتلو ةقیرط انمدختساLOO  میقلا نیب براقتلا ةدش انظحلا دقلو .ةیئاصحلاا رییاعملا ضعب كلذكو




Dans ce travail, une recherche fondamentale et originale sur l’hétérocycle 1,2,4-oxadiazol-5-amine est 
réalisée dans le but est de prédire de la réactivité et de l'activité biologique du composé étudié et ses dérivés.  
Les méthodes de modélisation moléculaire utilisées dans notre travail sont : RM1, HF/6-31++G(d, p) 
,MP2/6-31++G(d, p) et B3LYP/6-31++G(d, p). Ces méthodes ont été utilisées pour déterminer les 
paramètres structuraux, électroniques et énergétiques associés aux molécules étudiées. La nature de type de 
substituant influe sur les paramètres électroniques et énergétiques de noyau de base 1,2,4-oxadiazol-5-amine. 
En effet, cette étude nous permet de prédire la réactivité chimique des dérivés de 1,2,4-oxadiazol-5-amine. 
Une étude qualitative de la relation structure-propriétés (SPR) a été effectuée également pour une série 
bioactive de dérivés de 1,2,4-oxadiazol-5-amine. 
Une étude QSAR a été effectuée sur vingt molécules analogues de of 3-(aryl)-N-(aryl)-1,2,4-
oxadiazol-5-amines. Les composés utilisés sont caractérisés par son effet des agents antiprolifératifs. La 
régression linéaire multiple (MLR) a été utilisée pour quantifier les relations entre les descripteurs 
moléculaires et la propriété de l’activité antiprolifératif des dérivés du 1,2,4-oxadiazol-5-amine. La 
prédiction des modèles obtenus a été confirmé par la méthode de validation croisée LOO. Une forte 
corrélation a été observée entre les valeurs expérimentales et les valeurs prédites de l’activité 




In this work a fundamental  and original research on the 1,2,4-oxadiazol-5-amine heterocyclic, the aim 
is to predict the reactivity and biological activity of the compound studied and its derivatives.  
The molecular modeling methods used in our work are: RM1, HF/6-31++G(d, p), MP2/6-31++G(d, p) 
and B3LYP/6-31++G(d, p). These methods were used to determine the structural parameters, electronics and 
energy associated with molecules studied. The nature of such substituent (donor, acceptor) affects the 
electronic and energy parameters of basic core of 1,2,4-oxadiazol-5-amine. Indeed, this qualitative study 
allows us to predict the chemical reactivity of derivatives of 1,2,4-oxadiazol-5-amine.  
A study of  structure - property relationships (SPR) for 1,2,4-oxadiazole-5-amine derivatives has been 
carried out for a series of bioactive derivatives of 1,2,4-oxadiazol-5-amine. 
QSAR studies have been performed on twenty molecules of 3-(aryl)-N-(aryl)-1,2,4-oxadiazol-5-
amines as anti-proliferative agents, multiple linear regression analysis was performed to derive QSAR 
models which were further evaluated internally for the prediction of activity. The developed models were 
cross-validated by the ‘leave one out’ technique as well as by the calculation of statistical parameters. High 
correlation between experimental and predicted activity values was observed, indicating the validation and 
the good quality of the derived QSAR models. 
 
 
